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ABSTRACT 
Genome sequencing of lower eukaryotes such as fungi revealed high diversity of cytochrome 
P450 monooxygenases (P450s/CYPs) in their genomes compared to other biological 
kingdoms. For example, not only the presence of a large number of P450s was detected in 
many of their genomes, but also high diversity in terms of the number of P450 families. 
P450s are heme-thiolate proteins distributed across the biological kingdoms with immense 
catalytic diversity, which has prompted the use of these enzymes as potential catalysts for the 
production of fine chemicals, pharmaceutical compounds, antibiotics, fragrances and 
detoxification of carcinogenic and/or mutagenic compounds. Progress has been made in 
understanding P450s from lower eukaryotic organisms, which has led to the unravelling of 
their potential as anti-fungal drug targets. 
The lower eukaryotes belonging to the kingdom Stramenopila, especially phylum 
Oomycota species P450s, have been underexplored. Oomycetes are “hard-wired parasites” 
that remain a serious problem in agriculture and aquaculture and are counted among the most 
widespread and deadliest disease-causing agents of plants and crops worldwide. Their 
destructive behaviour lies in their ability to breach the host surface and break it down, 
promptly resulting in extensive destruction that hinders agricultural growth. The impact of 
oomycete species on the economy triggered various investigations on pathogenesis and 
control methods for these pathogens. 
In the quest to find a remedy, genome sequencing of oomycetes was carried out. 
Recently, the Unit for Drug Discovery Research’s laboratory (Department of Health 
Sciences, Faculty of Health and Environmental Sciences at the Central University of 
Technology) performed comprehensive comparative P450 genomics in 13 oomycete 
pathogens and discovered six novel P450s that can be used as drug targets against these 
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pathogens, particularly fish pathogens. The novel P450s belong to the CYP5619 family and 
were found in the fish pathogen Saprolegnia diclina. In order to use these P450s as novel 
drug targets, it is of the utmost importance to perform biochemical and biophysical 
characterisation of the family members. Hence, I am herewith proposing to perform in silico 
structural and functional analysis of CYP5619A1 from S. diclina, including cloning and 
generation of recombinant E. coli cells containing the CYP5619A1 gene in a novel expression 
vector and comprehensive phylogenetic analysis. This study is the first of its kind on analysis 
of the novel P450 family CYP5619 in microbes. 
 Phylogenetic analysis of CYP5619 family members across biological kingdoms 
revealed the presence of this novel P450 family in other oomycetes and in a phytoplankton. 
However, the number of CYP5169 members in organisms varied. Nine CYP5619 members 
were found in Achlya hypogyna and six were found in S. parasitica (both oomycetes). The 
oomycetes, Thraustotheca clavata and Aphanomyces invadans, were found to have three and 
two CYP5619 members, respectively. Emiliania huxleyi, a phytoplankton, was found to have 
two CYP5619 family members, but the smallest count was attributed to an oomycete, 
A. astaci (one CYP5619 member). This suggests that the CYP5619 family is present in other 
organisms apart for oomycetes.  
After performing phylogenetic analysis, a 3D model of CYP5619A1 from S. diclina 
was built by homology modeling and assessed for its binding affinity with different predicted 
substrates and with malachite green, a remedy used to treat S. diclina infections. The study 
revealed that eight of the compounds required low energy to bind to the target protein, with 
binding energies below -6.00 kcal/mol. This suggests that these ligands can act as possible 
substrates of CYP5619A1. Among all ligands, linoleic acid and malachite green showed a 
high binding affinity with the CYP5619A1 model. Linoleic acid is a polyunsaturated fatty 
© Central University of Technology, Free State
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acid with 18 carbon atoms and two double bonds in its structure. Malachite green is an 
organic compound that is widely used in aquaculture to treat S. diclina infections. These two 
compounds appeared to be the compounds with the best affinities to the target protein. In this 
regard, it is reasonable to believe that linoleic acid-like compounds could be potential 
substrates for CYP5619A1 and malachite green possibly inhibiting CYP5619A1 in S. diclina. 
In order to validate in silico results, CYP5619A1 was cloned into the newly designed 
vector pINK-d using in silico and in vitro techniques. The gene was cloned into the novel 
expression vector using the software pDRAW and the sequence of the designed primers, 
vector and gene of interest were sent to GenScript. The vector and vector with CYP5619A1 
obtained from GenScript were subjected to restriction enzyme analysis. The results obtained 
were satisfactory, as the gene was perfectly cloned into the vector, which was verified by 
running the plasmid through an agarose gel on the one hand, and the plasmid restricted by the 
KpnI and XbaI enzymes on the other hand. The gel analysis confirmed the presence of 
CYP5619A1. 
© Central University of Technology, Free State
CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
4 | P a g e  
 
CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
1.1. Essential fatty acids  
The human body synthesises fats it needs from the food we consume. Nevertheless, some 
important fats have to be taken in directly from natural sources, since they cannot be 
synthesised by the body, and are therefore termed “essential”. These essential fatty acids 
(EFAs) are also called polyunsaturated fatty acids (PUFAs), as they contain more than one 
double bond between carbon atoms and therefore, are not saturated with hydrogen. There are 
two families of PUFAs, namely the alpha-linolenic acid (LNL), and the linoleic acid (EIC) 
families. They are used to build specialised fats: the omega-3 and the omega-6 fatty acids, 
respectively (Groff et al., 1995). 
Once ingested, the LNL is converted to two long-chain PUFAs: eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), the two types of omega-3 fatty acids most readily 
used by the body. On the other hand, EIC is converted by the body upon ingestion, to the 
long-chain PUFAs gamma-linolenic acid (GLA) and arachidonic acid (www.nutri-facts.org). 
1.1.1. Role of essential fatty acids in humans 
It is necessary to have an adequate intake of PUFAs, as they play a crucial role in the proper 
development and functioning of organs. Indeed, they account for one of the most important 
requirements for the development of the brain and the maintenance of its function, as well as 
for good vision (www.nutri-facts.org).  Almost two thirds of the human brain is made up of 
phospholipids, which makes it the fattiest organ of the human body. For good development 
and integrity, it requires PUFAs such as DHA and EPA, as well as other micronutrients such 
as vitamins B, C and E, iron, zinc, copper or taurine. DHA is widely distributed in the 
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cerebral cortex, membranes of synaptic communication centres, mitochondria and the retina’s 
photoreceptors. It also accounts for 50% of neuronal membrane weight (Haag, 2003; Singh, 
2003). 
 Besides the role played by the PUFAs in brain development and functioning and the 
vision process, EFAs also help in the regulation of immune and inflammatory responses, as 
well as in hormonal regulation by producing hormone-like molecules. According to 
Hippocrates, “the food that is good for the heart is likely to be good for the brain”. Omega-3 
fatty acids DHA and EPA contribute to the regulation of blood pressure and the maintenance 
of triglycerides’ concentrations. Singh (2005) also reported some benefits of omega-3, 
including a reduction of thromboxane level and an increase of prostacyclin level (which lead 
to vasodilation and greater oxygen delivery to the organs), an increase of serotonin (“feel 
good” neurotransmitter) and acetylcholine (“memory boosting” chemical) levels, and the 
neutralisation of oxygen-free radicals. 
 Deficiencies in EFAs are found in patients fed intravenously, those with cystic fibrosis 
and those with chronic poor fat absorption. It is also found in infants who did not receive 
enough nutrients from their mothers during their pregnancies. Symptoms include vision and 
nerve problems, probably developed during the growth of the child, poor memory, heart and 
circulation issues, fatigue, mood swings, dry skin (www.nutri-facts.org), liver and kidney 
abnormalities, reduced growth rates and impaired immune functions (Linscheer & 
Vergroesen, 1994; Barnard & Raymond, 1999; Harvard Mental Health Letter, 2003). 
1.1.2. Daily requirements for humans 
Recently, the National Academies released the Dietary Reference Intakes Report for Energy 
and Macronutrients (Trumbo et al., 2002). Adequate intakes (AIs) have been set for EIC and 
LNL. The AI for EIC is 17 g/d and 12 g/d for men and women aged 19 to 50 years old, 
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respectively. The AI for LNL is 1.6 g/d and 1.1 g/d for men and women aged 19 to >70 years 
old, respectively.  
In 1999, the National Institutes of Health (NIH) sponsored an international workshop 
on the essentiality and recommended dietary intakes for omega-6 and omega-3 fatty acids. 
The NIH working group proposed AIs of 2–3% of total calories for EIC, 1% of total calories 
for LNL, and 0.3% of total calories for EPA and DHA. The working group further 
recommended intakes of EPA and DHA of ≥650 mg/d and a minimum of 300 mg/d of DHA 
during pregnancy and lactation (Simopoulos et al., 1999).  
Health Canada suggests a minimum of 3% of energy from omega-6 fatty acids and 
0.5% from omega-3 fatty acids or 1% for infants who do not receive a preformed source of 
EPA and DHA (Scientific Review Committee, 1990).  The United Kingdom recommends that 
1% of energy be from LNL and 0.5% from EPA and DHA combined (Hmso, 1994).  
While there are no official recommendations for vegetarians and vegans, it is not 
possible for this population to achieve the NIH working group’s proposed AIs for EPA and 
DHA. Even with the use of DHA-enriched eggs, some seaweed, and/or DHA supplements, 
the best vegetarians could do is to meet the recommended intakes for DHA. Some experts 
suggest that vegetarians (and others receiving no direct sources of EPA and DHA) at least 
double the recommended intakes of LNL (Davis & Kris-Etherton, 2003). This would suggest 
an intake of LNL in the range of 1–2%. The ratio of omega-6 to omega-3 fatty acids is often 
used to assess the balance between EFA in the diet, although there is some controversy as to 
its practical significance. For vegetarians and others who consume little, if any, EPA and 
DHA, the omega-6-to-omega-3 ratio is of greater relevance than for individuals who consume 
significant daily sources of EPA and DHA.  
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A number of recommendations have been made on the basis of the ratio of omega-6 to 
omega-3 fatty acids. The World Health Organisation and the Food and Agriculture 
Organisation (WHO and FAO) suggest a ratio of 5:1–10:1, Sweden recommends a ratio of 5:1 
(Nordic Working Group on Diet and Nutrition) (Becker et al., 2004), Canada recommends 
4:1–10:1 (Scientific Review Committee), and Japan recently changed its recommendation 
from 4:1 to 2:1 (Kris-Etherton et al., 2000). On the basis of the proposed AIs, the NIH 
suggests a ratio of 2:1–3:1 (Simopoulos et al., 1999). One study found that a ratio of 4:1 
allows for adequate conversion to DHA in healthy vegetarians (Indu & Ghafoorunissa, 1992). 
Another research group suggested that the optimal ratio to maximise the conversion of LNL 
to DHA is 2.3:1 (Masters, 1996). Given the rate of conversion of LNL to EPA and DHA, it 
has been suggested that a safe and adequate ratio for the vegetarian and vegan populations 
would be in the range of 2:1 to 4:1 (Davis & Melina, 2000). This can best be achieved by 
increasing LNL in the diet and decreasing EIC, if indicated. 
1.1.3. Sources of essential fatty acids 
Supplements containing omega-3 and omega-6 fatty acids are available, but the EFAs can 
also be found naturally in plant and animal products. Table 1.1 shows some common forms 
and different sources of those fatty acids, as well as some potential health-promoting benefits. 
From the information presented in table 1.1 it is clear that fish and fish products are the 
common source for EPA and DHA and are readily available for consumption. Thus, it is 
necessary to protect aquatic animals, especially fish, to ensure a continuous supply of EFAs to 
humans. 
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Table 1.1. Common forms, food sources and health benefits related to omega-3 and 
omega-6 fatty acids (Franzen-Castle & Ritter-Gooder, 2010). 
 Omega-3 fatty acids Omega-6 fatty acids 
Most commons forms Eicosapentaenoic  acid (EPA) 
Docosahexanoic acid (DHA), and 
Alpha-linolenic acid (LNL) 
Linoleic acid (EIC) mostly 
(85-90% of omega-6 fatty 
acids) 
Common food sources EPA and DHA – fatty fish 
(salmon, white tuna, mackerel, 
rainbow trout, herring, halibut 
and sardines) 
LNL – canola or soybean oil, 
walnuts and ground flaxseed or 
flaxseed oil 
Vegetable oils (corn, 
sunflower, safflower and 
soy), salad dressing, nuts, 





Reduce inflammation in heart 
disease, inflammatory bowel 
disease, and rheumatoid arthritis 
Help prevent blood from clotting 
and sticking to artery walls 
Help lower risk of blocked blood 
vessels and heart attacks 
Prevent hardening of the arteries 
Decrease risk of sudden death 
and abnormal heart rates 
Decrease triglyceride levels 
Lower blood pressure 
Neutral or lower levels of 
inflammatory markers 
Replacing saturated and 
transfat with omega-3 fatty 
acids associated with 
decreasing risk of heart 
disease 
Improve insulin resistance 
and reduce the incidence of 
diabetes 
Lower blood pressure 
Lower cholesterol levels 
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1.2. Oomycetes 
Long considered a class within the kingdom Fungi based on similarities in growth patterns, 
oomycetes have been subject to multiple studies. Traditional groupings based on morphology 
have been replaced by more advanced methods such as (i) the observation of structural 
characteristics through the transmission electron microscope developed in the 1970s, (ii) 
taxonomic analyses of phenotypic characteristics and (iii) sequence comparisons.   
1.2.1 Classification of oomycetes 
Oomycetes form a class under the superphylum Heterokonta, and the kingdom Stramenopila. 
Dick (2013) reported two subclasses, with six prominent orders. Below are some of the 
genera identified in the various orders: 
Subclass: Peronosporomycetidae 
Order: Peronosporales, e.g: Many genera of downy mildews, Albugo  
Order: Pythiales, e.g.: Pythium, Phytophthora  
Subclass: Saprolegniomycetidae 
Order: Saprolegniales, e.g.: Aphanomyces  
Order: Sclerosporales, e.g.: Downy mildews of the Poaceae, such as: Sclerospora, 
Peronosclerospora, Sclerophthora 
Order: Salilagenidiales, e.g. Lagena 
Order: Leptomitales  
Saprolegnia is the only genus of oomycete pathogens that does not contain plant 
pathogens, but it contains pathogens of different water-borne organisms such as crayfish and 
fish. Although Saprolegnia species are considered secondary pathogens, when given the 
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appropriate circumstances they would act as primary pathogens and cause mycoses. 
Typically, once an organism is infected the disease is fatal.  Scientists believe that extensive 
mortality of salmon and trout in Europe have been caused by Saprolegnia infection. 
Saprolegnia can parasitise fins and flesh, gaining initial infection through wounds.  It can also 
parasitise eggs and is often visible as a white cottony mass on the surface of eggs or fish in 
home aquaria. 
Recently, Saprolegnia ferax has been linked to the decline in amphibian populations.  
Apparently, climate change induced shallower water levels, which exposed eggs to higher 
levels of ultraviolet radiation. UV-B radiations have been reported to cause damage to the 
skin and have a strong immunosuppressive effect in fish. In the case of S. ferax infections, in 
addition to the above-mentioned effects, the number of mucus-producing goblet cells was 
observed to be reduced in UV-B-injured fish skin (Helbling et al., 2003). 
1.2.2. Characteristics of oomycetes 
Absorption of nutrients, production of mycelium, filamentous growth at the vegetative stage 
and formation of spores for sexual and asexual reproduction led researchers to consider 
oomycetes as fungi. However, recent studies revealed new characteristics of those pathogens 
that classify them as a distinct group, namely the heterokont algae. 
These heterokont algae form a distinctive group from the general algae in having 
motile zoospores with two types of flagella, to which the term “heterokont” refers. One of the 
flagella on the oospore is a whiplash oriented posteriorly and the other one is oriented 
anteriorly, with a fibrous, ciliated structure.  
Another characteristic of the oomycetes that distinguishes them from fungi is their 
sexual reproduction. In oomycetes, haploid gametes fertilise haploid oospheres, producing 
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diploid oospores as zygotes.  This is termed oogamous reproduction. One may observe a 
large, single oospore, or rather a cluster of small oospores, inside the oogonium. 
A third pattern that distinguishes oomycetes from true fungi is the composition of their 
cell walls. Fungi have cell walls made of chitin and cellulose. Nonetheless, this second pattern 
is rarely observable in the fungi. In the oomycetes, on the other hand, cellulose is an integral 
part of the cell wall, together with beta glucans, which are potent and proven non-specific 
immune response activators and modulators (Beta Glucan Research – Saccharomyces 
cerevisiae, from http://www.betaglucan.org/). 
Other particular characteristics of oomycetes are the nuclear state of the vegetative 
mycelium and the mitochondrial cristae’s shape. Indeed, the true fungi’s mycelium is septate 
and contains haploid nuclei; cells may as well be dikaryotic with two or more haploid nuclei. 
In the Oomycota, however, the organism is primarily in a diploid state: the vegetative cells 
generally consist of coenocytic (without septa) hyphae that contain diploid nuclei. On the 
other hand, fungi possess flattened mitochondrial cristae, while Oomycota’s are tubular, with 
protoplasmic- and nuclear-associated microtubules. This last characteristic was observed by 
dint of the development of the transmission electron microscope, allowing researchers to 
perceive differences in ultrastructure characteristics. More studies using molecular sequence 
data and mathematical algorithms came to support the established difference between 
Oomycota and fungi, by comparing sequence similarities in particular gene regions and 
analysing changes among the gene regions’ base pairs, leading to the conclusion that 
Oomycota mostly relate to the other members of the heterokont algae, rather than to fungi. 
1.2.3. Oomycete species and targets 
Oomycetes are organisms considered to be “hard-wired” for parasitism (Lamour & Kamoun, 
2009; Beakes, 2012) although some species from the order Peronosporales are mainly 
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saprophytes (Kamoun, 2003; Lamour & Kamoun, 2009). They cause diseases in both plants 
and animals (Kamoun, 2003; Phillips et al., 2008; Lamour & Kamoun, 2009). Oomycetes are 
counted among the most widespread and deadliest disease-causing agents of plants and crops 
worldwide. Their destructive behaviour in agriculture lies in their ability to breach the host 
plant’s surface and break it down, promptly resulting in extensive destruction that hinders 
agricultural growth (Soanes et al., 2007). There has been a huge impairment of aquaculture 
owing to oomycetes and as for plants, serious diseases are caused not only in agriculturally 
and ornamentally important plants, but also other plants in the environment. A summary of 
diseases caused by oomycetes is listed in Table 1.2.  
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Table 1.2. Oomycete species and general information, such as their host and diseases 
caused by these pathogenic species. 
Species name Host General information 
Phytophthora sojae and 
Phytophthora ramorum 
Plants These species are considered model species for the 
Phytophthora genus owing to well-developed 
genetic and genomics resources, including genetic 
maps, bacterial artificial chromosome (BAC) 
libraries and expressed sequence tag (EST) libraries. 
P. sojae causes soybean root and stem rot and leads 
to substantial yield losses annually.  P. ramorum 
causes sudden oak death, tanoak and ramorum 
blight on woody ornamental forest under canopy 
plants. It causes stem cankers on trees and leaf 
blight or stem dieback on ornamentals and under-
storey forest species. 
Phytophthora infestans Plants It is the causative agent of late blight disease in 
potato and tomato plants. Responsible for the 
famous Irish potato famine in the mid-nineteenth 
century. 
Phytophthora parasitica Plants A model species of oomycete pathogens. Causes 
destructive diseases in a wide variety of crops 
including tomato, eggplant, pepper, tobacco, potato, 
walnuts, fruits and a wide range of nursery and 
ornamental plants and forest ecosystems. 
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Phytophthora capsici Plants Attacks the roots, stems, leaves and fruit of pepper, 
resulting in damping-off, seedling blight, foliar 
blight and death. Other plants that are affected 
include tomato, eggplant, cucumber, watermelon, 
pumpkin, squash and cocoa. 
Hyaloperonospora  
arabidopsidis  (formerly 
Hyaloperonospora 
parasitica) 
Plant The causal agent of the downy mildew of the plant 
model organism Arabidopsis thaliana 
Pythium aphanidermatum Plants Causes damping off, root and stem rots, and blights 
of grasses and fruits, papaya, beets, pepper and 
cotton 
Pythium irregular Plants Highly pathogenic on wide range of cereal and 
leguminous plants 
Pythium awayamai Plants Isolated mainly from monocotyledon plants. Causes 
snow-rot disease of cereal plants including wheat 
and barley 
Pythium ultimum Plants Causes damping-off and root rot to diverse plant 
hosts, including crops and forests 
Pythium  vexan Plants Causes canker, damping-off and rot disease in many 
economically important crops, including rubber 
trees, potato and sugar cane 
Saprolegnia parasitica Animals One of the most important fish pathogens causing 
millions of dollars of losses to the aquatic culture 
business worldwide. It attacks a wide variety of fish, 
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amphibians and crustaceans. Members of this genus 
Saprolegnia causes “Saprolegniosis”, a disease that 
is characterised by visible white or grey patches of 
filamentous mycelium on the body and fins of 
freshwater fish. 
Saprolegnia diclina Animals Pathogen of amphibians, fish and insects. Plays a 
role in decline of natural populations of amphibians. 
Outbreaks leading to severe reductions and even 
extinction of amphibians have been attributed to this 
species.  It is also a large problem in fish hatcheries 
where it infects eggs of salmon and trout.  
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As shown in the table above, oomycetes also infect animals, mainly aquatic and to 
date, they have remained a serious problem in agriculture and aquaculture (Kamoun, 2003; 
Lamour & Kamoun, 2009; Phillips et al., 2008). Oomycete diseases are not commonly easy to 
control. Moreover, some oomycete species, particularly Phytophthora species, have the 
ability to build up resistance against chemicals by producing new genetically tougher strains. 
Plants are also very sensitive to oomycete attacks owing to their weak disease resistance. 
1.2.4. Economic importance of oomycetes 
Oomycetes are eukaryotic organisms that superﬁcially resemble ﬁlamentous fungi, but are 
phylogenetically related to diatoms and brown algae in the kingdom Stramenopila 
(Gunderson et al., 1987; Lamour & Kamoun, 2009; Thines & Kamoun, 2010; Jiang & Tyler, 
2012; Thines, 2014). The impact of oomycetes on humankind is well documented as both a 
persistent threat to subsistence and commercial farming and as destructive pathogens of native 
plants (Erwin, 1996; Agrios, 2005; Lamour & Kamoun, 2009). As a result, news related to 
plant diseases caused by oomycetes tends to capture the interest of the general public and is 
frequently featured in the media. 
S. ferax and S. diclina are causing declines in amphibian populations (Kiesecker et al., 
2001; Fernandez Benéitez et al., 2008). S. parasitica is known to be a devastating pathogen 
affecting many freshwater species of ﬁsh, and S. diclina is a potent pathogen of ﬁsh eggs. 
Both are currently causing signiﬁcant economic damage in the global ﬁsh farming industry 
(van West 2006; Phillips et al., 2008). Previously, S. parasitica and S. diclina infections were 
controlled with the biocide malachite green. However, there was a worldwide ban on the use 
of this chemical because of its potential toxicological and carcinogenic effects on both ﬁsh 
and consumers of fish (reviewed in Alderman, 1994; Marking et al., 1994). As a result of this 
ban, there has been a signiﬁcant increase in Saprolegnia infections (Robertson et al., 2009). 
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On ﬁsh, saprolegniosis is characterised by white or gray patches of cotton wool-like 
ﬁlamentous mycelia (Hatai & Hoshiai, 1992). In general, infection initially appears on 
epidermal tissues of the head, tail and ﬁns of the ﬁsh (Tiffney, 1939; Hatai & Hoshiai, 1992; 
Fregeneda Grandes et al., 2001; Hussein & Hatai, 2002), and it subsequently spreads to the 
rest of the body. Lesion areas may be soft, necrotic and ulcerated, and the surrounding areas 
may show oedema and necrosis (Gieseker et al., 2006). Saprolegniosis has been documented 
in a range of ﬁsh species, including Atlantic salmon (Salmo salar L.), brown trout, (Salmo 
trutta L.), coho salmon (Oncorhynchus kisutch), perch (Perca ﬂuviatilis), masu salmon 
(Oncorhynchus masou), rainbow trout (Oncorhynchus mykiss), Japanese char (Salvelinus 
leucomenis), sockeye salmon (Oncorhynchus nerka), channel catﬁsh (Ictalurus punctatus) 
(Tiffney, 1939; Hatai & Hoshiai, 1992; Bly et al., 1993; Hussein & Hatai, 2002; Stueland et 
al., 2005) and  freshwater crayﬁsh (Diéguez-Uribeondo et al., 1994), as well as in amphibians 
(Kieseker et al., 2001; Fernandez-Benéitez et al., 2008). 
Because of overﬁshing in the seas in recent years, ﬁsh production has become 
dependent on ﬁsh farming for an adequate supply and as a result, aquaculture has become the 
world’s fastest growing food sector. This fact is reﬂected in the astonishing increase in ﬁsh 
production through ﬁsh farming.  In 2004, a staggering 45.5 million tons of ﬁsh worth 
US$ 63.4 billion were farmed worldwide. This represents a 12.6% and 15.3% increase, 
respectively, over reported ﬁgures in 2002 (FAO Fishery Information: www.fao.org). 
Aquaculture has both social and economic importance in many countries, which include 
China, Canada, Chile, Japan, Norway, the United States and the United Kingdom. The 
greatest cause of economic loss in aquaculture is diseased ﬁsh, with bacterial diseases being 
the most common, closely followed by fungal and oomycete infections (Meyer, 1991). S. 
parasitica, a ubiquitous freshwater pathogen (Diéguez-Uribeondo et al., 2007), can infect not 
only a wide range of wild and farmed ﬁsh, but may also cause infection in hobby ﬁsh tanks.  
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In Japanese freshwater ponds, Saprolegnia species are among the main causes of 
infection of salmon fish (Hussein & Hatai, 2002). S. parasitica has been reported to cause 
mass mortality of coho salmon in Japanese salmon farms (Hatai & Hoshiai, 1992). 
S. parasitica is also the cause of the disease termed ‘‘winter kill,’’ which affects catﬁsh in the 
United States and causes signiﬁcant ﬁnancial losses in the farming of this ﬁsh (Bly et al., 
1992). In Chile, one of the main ﬁsh-producing countries, S. parasitica has become a major 
threat to farms of Atlantic salmon, coho salmon, and rainbow trout (Zaror et al., 2004). In 
addition to aquaculture, S. parasitica has been reported to have a major impact on wild ﬁsh 
populations globally. Saprolegnia species have been isolated from head burn lesions of wild 
adult Chinook and steelhead salmon. The disease is also having a signiﬁcant impact on the 
populations of these species in the Northwest United States, where up to 22% of returning 
salmon die as a result of headburn lesions that have become infected with S. parasitica 
(Neitzel et al., 2004). 
1.3. Cytochrome P450 monooxygenases 
1.3.1. Generalities on cytochrome P450 monooxygenases 
Cytochrome P450 monooxygenases (also called CYPs or P450s) are heme-thiolate proteins 
that form a very diverse protein superfamily and play a role in metabolising drugs and 
numerous other xenobiotics (Nelson, 2013). They are found in almost every living species, 
with extremely few exceptions, such as the gram-negative bacteria Escherichia coli. 
Nonetheless, on a greater scale, they have been documented to belong to every phylogenetic 
domain of life, ranging from microscopic prokaryotes to complex eukaryotes (Nelson, 2013). 
The highest number of P450 genes belongs to the kingdom Plantae. Nevertheless, the 
kingdom Fungi possesses the highest number of P450 families, which denotes higher 
diversity in that kingdom. As a matter of fact, 399 P450 families are located throughout the 
2 784 annotated fungal P450s in comparison to plant genomes having only 129 P450 families 
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located throughout the 4267 annotated plant P450s (Nelson, 2009; Nelson, 2011). To date, 
more than 21 000 P450s have been sequenced, annotated and described (Nelson, 2009). 
Through evolution, they have enabled organisms to adapt to the different changes that 
occurred, geographically and ecologically. Examples are documented and include adaptation 
to elevated hydrostatic pressures and temperatures of solfataric hot springs (Park et al., 2002; 
David et al., 2013; Nelson, 2013) and adaption in the utilisation of photosynthetically fixed 
carbon such as wood (Syed et al., 2014a, 2014b). 
The term ‘cytochrome P450’ was coined in 1962 as a temporary name for a coloured 
substance in the cell (Omura & Sato, 1962). This pigment (abbreviated ‘P’ in the naming), 
when reduced and bound with carbon monoxide, produced an unusual absorption peak at a 
wavelength of 450 nm (Figure 1.1), thus P (for pigment) and 450 (for the wavelength). The 
cysteine-thiolate group is the prime reason for this phenomenal spectral display observed in 
P450s. ‘Cytochrome’ is a misnomer, given that P450s are enzymes rather than true 
cytochromes or single entities. On the other hand, there is an observed formation of the fifth 
ligand of the heme-iron, hence the name heme-thiolate proteins or haemoproteins is given to 
P450 enzymes (Omura & Sato, 1962). Despite this, the name ‘cytochrome P450’ has stuck 
and is so widely accepted that any change would be impractical. At first, P450s were believed 
to represent single enzymes. Today, it seems likely that humans and other mammals have 
approximately 50 distinct P450 enzymes. The total number may be higher in plants, possibly 
as high as several hundred. In the last 15 years of the 20
th
 century, research was largely 
concerned with defining P450 multiplicity in humans and a diverse range of other organisms.  
Several diverse P450 nomenclature systems have emerged based on their molecular 
weights or preferences for substrates. The resultant plethora of names and accompanying 
confusion prompted prominent workers in the field to devise a standard nomenclature for the 
P450 gene family based on amino acid sequence comparisons and the evolutionary 
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relationships of the corresponding genes (Nebert et al., 1987). First proposed in 1987, the 
nomenclature was devised on the premise that it would be updated as frequently as the 
identification of new P450 enzymes necessitated. Several updates of the P450 gene 
superfamily have been published (Nebert et al., 1989; Nebert et al., 1991; Nelson et al., 1993; 
Nelson et al., 1996). In addition, an official website has been established, based at the 
University of Memphis, to provide up-to-date information on P450 multiplicity in all species 
(Nelson, 2006). 
Nomenclature recommendations CYP450 (Nebert et al., 1987; Nebert et al., 1991; 
Nelson, 2009) for naming a gene include:  
• The root symbol CYP for ‘cytochrome P450’;  
• An Arabic number for the P450 family (at least 40% sequence homology);  
• A letter for the subfamily (more than 55% sequence homology); and  
• An Arabic numeral for the individual gene.  
When describing a P450 gene, all letters and numerals are written in italics. The same 
nomenclature is recommended for the enzyme, but it is written in non-italicised form. Thus, 
the CYP2D6 gene encodes the CYP2D6 enzyme. 
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Figure 1.1: Typical cytochrome P450 reduced-CO difference spectrum (taken from 
Guengerich et al., 2009). The P450 spectral assay is based on the principle that the ferrous 
form (Fe
2+
) of the hemoprotein reacts with the carbon monoxide (CO) to form a CO-bound 
complex that distinctively generates a spectrum with maximum absorption at a wavelength of 
450 nm (shown in red), as a result of the cysteine-thiolate axial ligand bound to the haem iron 
molecules present in the P450 enzymes. 
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1.3.2. P450s’ role in drug development or as drug targets 
The P450 gene family, which encodes the P450 enzyme system, is one of the most widely 
studied topics in drug development. The drug-metabolising enzymes, which belong to the 
P450 family, are polymorphic (meaning that they have more than one variant of the gene). 
P450s have been shown to play highly important roles in the metabolism of drugs and 
xenobiotics, as well as in the biosynthesis of a variety of endogenous compounds, many of 
them displaying hormonal function. The role of P450s as therapeutic targets is still 
inadequately recognised, although several P450 inhibitors became efficient drugs that even 
reached blockbuster status.  
Whereas the majority of clinically used drugs are inactivated by P450s, several 
prodrugs are bio-converted to their active species by these enzymes. Therefore, this 
mechanism has been exploited to a greater extent, e.g. by taking advantage of the different 
P450 enzymes to achieve targeted drug delivery, to improve efficacy or to decrease the 
unwanted adverse effects of existing and novel drug molecules (Huttunen et al. 2008). 
P450s are key enzymes in cancer formation and cancer treatment. They mediate the 
metabolic activation of numerous pre-carcinogens and participate in the inactivation and 
activation of anticancer drugs (Rodriguez-Antona & Ingelman-Sundberg, 2006).  For that 
reason, a major objective of cancer research is the development of therapeutic agents 
speciﬁcally targeted at tumour cells. 
P450s expressed at higher levels in the tumour cells than in the surrounding normal 
tissue offer therapeutic options by the activation of prodrugs speciﬁcally in the cancer cells 
and avoiding undesirable systemic effects (Riddick et al., 2005). In this respect, there are 
therapeutic options and opportunities arising from both the enhanced endogenous expression 
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of P450 in tumours and P450-mediated gene therapy. Concerning endogenous overexpression 
of individual forms of P450 enzymes in tumour cells, CYP1B1 has been the best studied 
example, because although several CYP1As, CYP2Cs and CYP3As exhibit enhanced 
expression in some tumour cells, these enzymes also display considerable expression in 
normal tissue, mainly in the liver. On the other hand, CYP1B1 mRNA and protein expression 
have been found in a wide range of malignant tumours and in metastatic disease (McFadyen 
et al., 2001), but the CYP1B1 protein is generally not detected in normal tissue at important 
levels (Gibson et al., 2003). 
Another P450 used as a drug target is the CYP2W1. In cancer tissues and transfected 
cells, CYP2W1 gives multiple immunoreactivity bands, suggesting that the protein might be 
subjected to posttranslational modifications. In vitro and in vivo studies revealed that 
CYP2W1 undergoes glycosylation at Asn177, which is enabled by the unique inverted 
topology of the protein in the endoplasmic reticulum membrane. Regardless of the reversed 
emplacement, CYP2W1 retains its catalytic function in cell systems and is capable of 
converting inactive substrates to potent cytotoxic species, demonstrating the potential for 
prodrug activation. Efficient prodrugs have been developed, providing a basis for a novel 
therapeutic approach in colon cancer chemotherapy (Travica et al., 2013). 
Moreover, P450s are the target of special interest in the development of drugs for skin 
diseases because most – if not all – drugs available in the armamentarium of dermatologists 
are substrates, inducers, or inhibitors of this enzyme family. The functional significance of 
drug metabolism in skin and the implication of P450s in skin pathology and therapy is an area 
for future investigation. Detailed insight into the mechanism of action of various cutaneous 
P450s, being capable of modulating the drug bioavailability, will be helpful in the 
development of better strategies for novel therapy against constantly increasing skin disorders 
(Ahmad & Mukhtar, 2004). 
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1.4. CYP5619: A novel P450 family 
Researchers across the world are trying to understand oomycetes to control the diseases they 
cause and develop novel drugs against these pathogens. In this regard, researchers from the 
Unit for Drug Discovery Research, Department of Health Sciences, Faculty of Health and 
Environmental Sciences, Central University of Technology (CUT), analysed P450 proteins in 
13 pathogenic oomycete genomes (Sello et al., 2015) (Table 1.3). Genome-wide identification 
and annotation of P450s in the 13 oomycetes belonging to two different classes and three 
different orders revealed the presence of a moderate number of P450s in their genomes. The 
analysis also resulted in the discovery of a novel P450 monooxygenase protein family, 
namely the CYP5619. Members of this novel P450 family are fusion proteins with an N-
terminal P450 domain fused to a heme-dioxygenase/peroxidase domain (Sello et al. 2015) 
(Figure 1.2). This protein family was discovered in S. diclina. The authors suggested that 
members of this P450 family can serve as novel drug targets against oomycete pathogens. 
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Table 1.3. Comparative analysis of P450s in oomycetes (taken from Sello et al., 2015). 
Species name No. of P450s No. of P450 families 
No. of P450 
subfamilies 
Phytophthora sojae 30 4 18 
Phytophthora parasitica 31 4 18 
Phytophthora ramorum 24 4 17 
Phytophthora infestans 20 3 14 
Phytophthora capsici 28 3 17 
Hyaloperonospora arabidopsidis 7 2 7 
Pythium irregulare 41 3 17 
Pythium aphanidermatum 31 4 18 
Pythium ultimum 19 3 12 
Pythium iwayamai 42 3 19 
Pythium vexan 20 4 15 
Saprolegnia parasitica 24 6 16 
Saprolegnia diclina 39 9 26 
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Figure 1.2. Phylogenetic analysis of oomycetes novel P450 family CYP5619 with other 
fused P450 family members from fungi (taken from Sello et al., 2015). 
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1.5. Rationale and aims of the study 
Genome sequencing of lower eukaryotes such as fungi revealed high diversity in their 
genomes compared to other biological kingdoms (Sello et al., 2015). For example, not only 
was the presence of a large number of P450s detected in many of their genomes, but also high 
diversity in terms of the number of P450 families (Sello et al., 2015). P450s are heme-thiolate 
proteins distributed across the biological kingdoms (Nelson, 2013) with immense catalytic 
activity and diverse substrate acceptance, which have prompted the use of these enzymes as 
potential catalysts for the production of fine chemicals (Guengerich, 2002), pharmaceutical 
compounds (Ingelman-Sundberg, 2004; Guengerich, 2006), antibiotics, fragrances and 
detoxification of carcinogenic and/or mutagenic compounds (Urlacher & Eiben, 2006). 
Progress has been made in understanding P450s from lower eukaryotic organisms, which led 
to the unravelling of their potential as anti-fungal drug targets (Yoshida, 1988; Jawallapersand 
et al., 2014). 
The lower eukaryotes belonging to the kingdom Stramenopila, especially phylum 
Oomycota species P450s, have been underexplored. Oomycetes are “hard-wired parasites” 
that remain a serious problem in agriculture and aquaculture (Phillips et al., 2008) and are 
counted among the most widespread and deadliest disease-causing agents of plants and crops 
worldwide. The impact of oomycete species on the economy triggered various investigations 
on pathogenesis and control methods for these pathogens. 
In the quest to find a remedy, genome sequencing of oomycetes was carried out (Haas 
et al., 2009). Recently, comprehensive comparative P450 genomics in 13 oomycete pathogens 
was performed by laboratory of the Unit for Drug Discovery Research at CUT, leading to the 
discovery of a novel P450 that can be used as a drug target against these pathogens, 
particularly fish pathogens (Sello et al., 2014). The novel P450s belong to the CYP5619 
family. In order to use this family’s members as novel drug targets, it is of the utmost 
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importance to perform biochemical and biophysical characterisation of the members. Hence, 
the present research is proposing to perform in silico structural and functional analysis of 
CYP5619A1 from S. diclina as well as cloning and generation of recombinant E. coli cells 
containing the CYP5619A1 gene in a novel expression vector.   
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CHAPTER 2 
PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 
FAMILY CYP5619 FROM SAPROLEGNIA DICLINA 
2.1. Introduction 
Cytochrome P450 monooxygenases (CYPs or P450s) have potential biotechnological values, 
including their use as drug targets against pathogens (Kelly & Kelly, 2013; Jawallapersand et 
al., 2014). Some of their functions include the catabolism of compounds used as carbon 
sources by the host organism, as well as the synthesis of biologically active compounds such 
as prostaglandins, steroids and arachidonate metabolites. A high percentage of P450s’ 
substrates are hydrophobic compounds. Products of P450s activity are made more water-
soluble by monooxygenation. Because of this reaction of P450 and their substrates, some 
authors suggested that P450s could be engineered to break down environmentally toxic 
compounds such as polycyclic aromatic hydrocarbons and fluorocarbons (Urlacher & Eiben, 
2006). Another perspective in P450 application is the use of these proteins in the 
monooxygenation of compounds in a region- and stereo-selective manner to obtain products 
that have been proven to be of great value in biological processes. For example, P450s can be 
used to convert arachidonic acid to 14,15- epoxyeicosatrienoic acid, found to play a major 
role in the regulation of potassium and calcium influx in kidneys (Graham-Lorence et al., 
1997; Chen et al., 1999). It is therefore of the utmost importance to have a good 
understanding of P450s’ structures and eventually their catalytic mechanism, to accomplish 
these projects. 
P450s have been reported to have a common structural fold for all determined 
structures (Graham & Peterson, 1999; Sirim et al., 2010). They have enough diversity in the 
primary, secondary, and tertiary sequences to accommodate specific substrates and redox 
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partners and additionally to target the cellular location of the protein. Redox partners are key 
proteins in the functionality of P450s (Hannemann et al., 2007). They form systems that have 
been shown to be extremely diverse. Usually fused to their redox partner, some P450s have 
nevertheless been reported to stand alone, and others to be separated from their protein partner 
(Guengerich & Munro, 2013) (Figure 2.1). 
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Figure 2.1. Diversity of P450 redox systems and P450 fusion proteins (taken from 
Guengerich & Munro, 2013). A selection of distinct types of P450 enzymes and (where 
relevant) their redox partner systems is shown. The sizes of the boxes are indicative of the 
lengths of the protein modules. Bound prosthetic groups are indicated in the colour-coded 
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domains. A, P450BM-3 (CYP102A1)-type P450-CPR fusion, also seen for fungal P450foxy 
(CYP505)-type systems (Munro et al., 2002). B, CYP116B-type P450-phthalate dioxygenase 
reductase fusion (Warman et al., 2012). C, M. capsulatus P450-FDx fusion CYP51FX 
(Jackson et al., 2002). D, R. rhodochrous P450-flavodoxin fusion XplA, involved in reductive 
degradation of explosives (Rylott et al., 2011). E, Pseudomonas fluorescens PfO-1 acyl-CoA 
dehydrogenase-P450 fusion CYP222A1. This protein is depicted with FAD bound in its N-
terminal domain, but there is no report to date of characterisation of this protein. F, Mimivirus 
CYP5253A1, with a P450 fused to a C-terminal domain of uncertain function but containing 
several potential sites for post-translational modification. G, PpoA dioxygenase/peroxidase-
P450 fusion enzyme from A. nidulans, involved in Psi factor production (Brodhun et al., 
2009). H, P450-hydrolase fusion CYP631B5, involved in mycophenolic acid production 
(Hansen et al., 2012). I, “stand-alone” P450 that acts without partner proteins, typified by 
P450nor (CYP55A)-type nitric-oxide reductase enzymes that interact directly with NAD(P)H, 
peroxygenase CYP152 P450s that use H2O2 to oxidize substrates, P450s that isomerize 
substrates (e.g. CYP5A1/8A1), and allene oxide synthase (CYP74A) dehydratase P450s. J, 
typical eukaryotic Class II P450 systems with separate membrane-associated P450 and a CPR 
partner. K, Class I (mitochondrial) P450 system that interacts with the iron-sulphur protein 
ADx, which is in turn reduced by ADR. Most bacterial systems use a similar redox apparatus 
(Munro et al., 2007). L, variation on system K, in which a flavodoxin replaces the iron-
sulphur protein. This type of system supports CYP176A1 (P450cin), enables Citrobacter 
braakii to catabolise cineole and can reduce CYP107H1 (P450BioI), involved in Bacillus 
subtilis biotin synthesis (Lawson et al., 2004; Hawkes et al., 2010). M, heme-free EryCII 
P450-like protein devoid of a cysteine proximal ligand. EryCII is an allosteric activator of the 
glycosyltransferase EryCIII in the production of erythromycin D in Saccharopolyspora 
erythraea (Moncrieffe et al., 2012).  
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P450s have been underexplored in the kingdom Stramenopila, especially in the 
phylum Oomycota. Species from that phylum are “hard-wired” parasites, fungi-like 
organisms, well known for causing diseases in plants and animals, resulting in a huge 
financial loss in aquafarming and agriculture (Phillips et al., 2008). Research has been done to 
understand these pathogens and in order to find a remedy, genome sequencing of oomycetes 
has been carried out (Haas et al., 2009). In this direction recently the Unit for Drug Discovery 
Research (UDDR)’s laboratory at CUT completed comparative P450 genomics in the 13 
oomycetes (Sello et al., 2015). Annotation of P450s in 13 oomycetes resulted in the discovery 
of a novel P450 family, namely the CYP5619 family in Saprolegnia diclina, with a P450 
domain at the N-terminal, and a peroxidase domain at the C-terminal (Sello et al., 2015) 
(Figure 2.2).  
However, to date, study on analysis of CYP5619 P450s in other biological kingdoms 
or secondary structure analysis with respect to P450 helices and sheets has not been reported. 
This chapter is aimed at performing phylogenetic and secondary structure analysis of the 
CYP5619 family. 
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Figure 2.2. P450 fusion proteins pattern observed in Saprolegnia diclina. The N- terminal 
P450 is fused to a C-terminal heme-peroxidase domain. 
 
  
© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
46 | P a g e  
 
2.2. Methodology 
2.2.1. Sequence retrieval 
The protein sequences of six members of the CYP5619 family, namely CYP5619A1 (ID: 
SDRG_14280.1), CYP5619B1 (ID: SDRG_14281.1), CYP5619B2 (ID: SDRG_14277.1), 
CYP5619C1 (ID: SDRG_14273.1), CYP5619D1 (ID: SDRG_03324.1) and CYP5619D2 (ID: 
SDRG_14279.1), were obtained from an article published by researchers at the CUT 
laboratory (Sello et al., 2015). Protein IDs of CYP5619 family members are shown in 
parenthesis.  
2.2.2. Identification of CYP5619 homologs 
The CYP5619 members’ amino acid sequences were subjected to a protein Basic Local 
Alignment Search Tool (BLASTp) analysis against all sequences at the NCBI website. For 
each P450, a set of 100 homologs was downloaded. The homologs for each P450 were 
subjected to a batch search on the conserved domain database (CDD) (Marchler-Bauer et al., 
2010, 2014) in order to identify the domains present in the sequences. The results were 
downloaded and sorted. Hits exhibiting the presence of both a P450 and lipoxygenase 
domains were retained and the others were removed. Sequences with a different conformation 
compared to CYP5619 family members (P450 domain at the N- terminal and lipoxygenase 
domain at the C-terminal) were also removed from the analysis.    
2.2.3. Annotation and classification 
Based on the identity percentage, family and subfamily names were assigned. For assigning 
the family and subfamily names, the standard rule set by the International P450 Nomenclature 
Committee was followed, i.e. P450s within a family share more than 40% amino acid 
homology and members of subfamilies share more than 55% amino acid homology. 
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Furthermore, P450s that showed less than 40% homology with the target P450s were assigned 
to a new family. 
2.2.4. Phylogenetic analysis 
Phylogenetic analysis of P450s was carried out in the same way as described in recent 
publications from the UDDR’s laboratory at the CUT (Syed et al., 2014a, 2014b). Briefly, 
evolutionary analysis was carried out using the minimum evolution method16. The 
phylogenetic analysis was carried out using Molecular Evolutionary Genetics Analysis 
(MEGA 5.05) software (Tamura et al., 2011). 
2.2.5. Secondary structure prediction 
The PROfile Multiple Alignment with Local Structures and 3D constraints (PROMALS3D) 
(Pie et al., 2008) was used to align protein sequences and to predict secondary structure 
alignments. It is important to note that PROMALS3D aligns multiple protein sequences 
and/or structures, with enhanced information from database searches, secondary structure 
prediction, 3D structures or user-defined constraints and would also give the conservation 
index. 
2.2.6. Analysis of amino acids conservation 
This section was conducted using the results from the target-template alignment provided by 
the PROMALS3D server.  
2.3. Results and discussion 
2.3.1. CYP5619 members’ homologs 
The BLAST search revealed the presence of a moderate number of P450 sequences with the 
same conformation as that of CYP5619 family members. Based on their percentage identities, 
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the sequences were assigned to new families and subfamilies. In total, 24 P450s belonging to 
six species were found to have both P450 and heme-peroxidase/lipoxygenase motifs, with the 
former being N-terminal and the latter fused at its C-terminal. The P450s were grouped into 
two families (CYP5619 and new family) families and five subfamilies (A, B, C, D, and new 
subfamily) (Figure 2.1 and Tables 2.1 and 2.2). 
2.3.2. Phylogenetic analysis 
The BLAST search coupled with the phylogenetic analysis of CYP5619 family members 
across biological kingdoms revealed the presence of this novel family in other oomycete 
organisms and in a phytoplankton (Figure 2.1. and Table 2.2). However, the number of 
CYP5169 members in organisms varied (Table 2.2). Nine CYP5619 members were found in 
Achlya hypogyna and six were found in S. parasitica (both oomycetes). Thraustotheca 
clavata and Aphanomyces invadans (both oomycetes) were found to have three and two 
CYP5619 members, respectively. One organism (Emiliania huxleyi) of the phytoplankton was 
found to have two CYP5619 family members, but the smallest count was attributed to an 
oomycete: A. astaci. 
Phylogenetic analysis resulted in alignment of the same subfamily members together, 
suggesting the nomenclature is correct (Figure 2.3). The new family and subfamilies are 
grouped together (Figure 2.3). 
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Table 2.1. Annotation of hit proteins. Standard P450 nomenclature was followed to assign families and subfamilies to different P450s. 
P450 name Protein ID Specie source 
Reference P450 
% Id Homolog P450 Specie source 
NF1SF1 XP_005786468.1 
 
Emiliania huxleyi CCMP 1516 96.42 XP_005778763.1 Emiliania huxleyi CCMP 1516 
NF1SF1 XP_005778763.1 Emiliania huxleyi CCMP 1516 96.42 XP_005786468.1 Emiliania huxleyi CCMP 1516 
CYP5619NSF1 2OQR84833.1 Achlya hypogyna 50.37 CYP5619C1 Saprolegnia diclina VS20 
CYP5619NSF1 XP_012203940. 1 Saprolegnia parasitica CBS 223.65 50.47 CYP5619C1 Saprolegnia diclina VS20 
 2OQR84833.1 Achlya hypogyna 62.59 XP_012203940.1 Saprolegnia parasitica CBS 223.65 
CYP5619D XP_012194083.1 Saprolegnia parasitica CBS 223.65 92.38 CYP5619D1 Saprolegnia diclina VS20 
CYP5619D AIG56338.1 Achlya hypogyna 64.77 CYP5619D1 Saprolegnia diclina VS20 
CYP5619D AIG56100.1 Achlya hypogyna 62.83 CYP5619D1 Saprolegnia diclina VS20 
CYP5619D AIG56283.1 Achlya hypogyna 62.30 CYP5619D1 Saprolegnia diclina VS20 
CYP5619C XP_008878127.1 Aphanomyces invadans 56.15 CYP5619C1  Saprolegnia diclina VS20 
CYP5619C XP_008879406.1 Aphanomyces invadans 57.17 CYP5619C1 Saprolegnia diclina VS20 
CYP5619C XP_009834503.1  Aphanomyces astaci 77.22 XP_008879406.1 Aphanomyces invadans 
CYP5619A OQS03666.1 Thraustotheca clavata 58.50 CYP5619A1 Saprolegnia diclina VS20 
CYP5619A OQS07119.1 Thraustotheca clavata 64.92 OQS03666.1 Thraustotheca clavata 
CYP5619C XP_012203939.1 Saprolegnia parasitica CBS 223.65 95.65 CYP5619C1 Saprolegnia diclina VS20 
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CYP5619C OQR84821.1 Achlya hypogyna 74.67 CYP5619C1 Saprolegnia diclina VS20 
CYP5619C 1OQR84833.1 Achlya hypogyna 79.57 CYP5619C1 Saprolegnia diclina VS20 
CYP5619B 1OQR84828.1  Achlya hypogyna 69.08 CYP5619B1 Saprolegnia diclina VS20 
CYP5619B XP_012203946.1 Saprolegnia parasitica CBS 223.65 92.98 CYP5619B1 Saprolegnia diclina VS20 
CYP5619B OQR84819.1 Achlya hypogyna 75.29 CYP5619B2 Saprolegnia diclina VS20 
CYP5619B XP_012203942.1 Saprolegnia parasitica CBS 223.65 90.69 CYP5619B2 Saprolegnia diclina VS20 
CYP5619A OQS07110.1 Thraustotheca clavata 65.67 CYP5619A1 Saprolegnia diclina VS20 
CYP5619A 2OQR84828.1 Achlya hypogyna 77.71 CYP5619A1 Saprolegnia diclina VS20 
CYP5619A XP_012203945.1 Saprolegnia parasitica CBS 223.65 95.88 CYP5619A1 Saprolegnia diclina VS20 
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Table 2.2. Homolog CYP5619 P450 family members from NCBI blast results. All hit 
proteins were sorted into P450 family domains using the NCBI CDD database (see Appendix) 
and proteins with N-terminal P450 and C-terminal dioxygenase, the same as CYP5619A1, 
CYP5619B1, CYP5619B2, CYP5619C1, CYP5619D1 and CYP5619D2, were selected for 
the study.  
Hit protein ID Species name Nature of species 
1OQR84828.1 Achlya hypogyna Oomycete 
1OQR84833.1 Achlya hypogyna Oomycete 
2OQR84828.1 Achlya hypogyna Oomycete 
2OQR84833.1 Achlya hypogyna Oomycete 
AIG56100.1 Achlya hypogyna Oomycete 
AIG56283.1 Achlya hypogyna Oomycete 
AIG56338.1 Achlya hypogyna Oomycete 
OQR84819.1 Achlya hypogyna Oomycete 
OQR84821.1 Achlya hypogyna Oomycete 
OQS03666.1 Thraustotheca clavata Oomycete 
OQS07110.1 Thraustotheca clavata Oomycete 
OQS07119.1 Thraustotheca clavata Oomycete 
XP_005778763.1 Emiliania huxleyi CCMP1516 Phytoplankton 
XP_005786468.1 Emiliania huxleyi CCMP1516 Phytoplankton 
XP_008878127.1 Aphanomyces invadans Oomycete 
XP_008879406.1 Aphanomyces invadans Oomycete 
XP_009834503.1 Aphanomyces astaci Oomycete 
XP_012194083.1 Saprolegnia parasitica CBS223.65 Oomycete 
XP_012203939.1 Saprolegnia parasitica CBS223.65 Oomycete 
XP_012203940.1 Saprolegnia parasitica CBS223.65 Oomycete 
XP_012203942.1 Saprolegnia parasitica CBS223.65 Oomycete 
XP_012203945.1 Saprolegnia parasitica CBS223.65 Oomycete 
XP_012203946.1 Saprolegnia parasitica CBS223.65 Oomycete 
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Figure 2.3. Evolutionary analysis of CYP5169 family members. The evolutionary history 
was inferred using the neighbour-joining method (Saitou & Nei, 1987). The optimal tree with 
a sum of branch length = 2397.51806641 is shown. The tree is drawn to scale, with branch 
lengths in the same units as those of the evolutionary distances used to infer the phylogenetic 
tree. The evolutionary distances were computed using the number of differences method (Nei 
& Kumar, 2000) and are in the units of the number of amino acid differences per sequence. 
The analysis involved 30 amino acid sequences. All positions with less than 95% site 
coverage were eliminated. That is, fewer than 5% alignment gaps, missing data, and 
ambiguous bases were allowed at any position. There were a total of 547 positions in the final 
dataset. Evolutionary analyses were conducted in MEGA5 (Tamura et al., 2011). CYP51F1 of 
Saccharomyces cerevisiae is used as outgroup. Different CYP5619 subfamilies were indicated 
with different colours. 
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2.3.3. Conservation of the secondary structure 
The detailed secondary structure analysis of the CYP5619 family members was shown in 
Figure 2.4. The helices and beta-sheets follow the P450 fold pattern as described by some 
authors (Graham & Peterson, 1999; Sirim et al., 2010), with a few exceptions such as the 
CYP5619D subfamily members not showing the supposedly conserved helix L, or the 
CYP5619C1 lacking the supposedly conserved sheets β1_1, β1_2, β1_4, β1_5 and β2_1. 
Nevertheless, a high conservation index (conservation index 9) was observed in helix K with 
the ExxR motif (shaded cyan in Figure 2.4), predicted to be involved in the stabilisation of the 
core structure. Also, prior to the L-helix, which forms part of the heme-binding region, lies 
the conserved Cysteine, which is responsible for the 450 nm Soret absorbance observed in 
CO-bound proteins. It is part of the CxG motif (highlighted in cyan in Figure 2.4), but not 
present in CYP5619D subfamily. 
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Conservation:                             6     6     6                  6 6    6  6  96 6 
CYP5619D1_       1  ----------------------MVSLPLLVIVIVGQVAGAPQGLGSVLQGVINDVKHSVAGVRYVFESLV   48 
CYP5619D2        1  ----------------------MVALVPLLLTAVGVVGTQENTLKGFFQGVISDIKHAVTDVRYTFESLV   48 
CYP5619A1_       1  MGNLTST---GATHGD-------VHMDKMVMYLDGDRS-------AMM-----D------GDLFVLEKAL   42 
CYP5619C1        1  MGNQPST---EAGVAPLPDSKRANSIFSLLAFAKDPKA-------AMA-----ESR-DTLGNLFLIESAV   54 
CYP5619B2_       1  MGNEASTVHADGAATDLPASHRAMNILKMIEFSKDPRA-------GML-----ESR-DQFGDLFLLESHL   57 
CYP5619B1_       1  MGSQAST---PAGAA--PSLRRAASLKKMIMFMKDPRT-------AMM-----DCR-DHYGDVFLMESSL   52 
Consensus_aa:       ......................hhsl..hlbh..ss.t.......thh.....-s+.s.hGs.@lhEShl 
Consensus_ss:                               ehhhhhhhhh hhh     hhhhhhhhh hhhhhhhhheeeeeeee 
 
 
Conservation:         966 999696 9  69  6  9   9  9 9 9   9 96   9 96  6  66   6 966   9 
CYP5619D1_      49  DAEPVTGFCSPEALRAFDDALASGALERRTAYPTGILELTGPTLSTIDGPAFLKRQDAFLNALSGAALST  118 
CYP5619D2       49  NAEPVTGFCSPDALRAFDDALSSGALSRHAAYPAGLLDLSGPTLSTLDGQAFAIRQESLLNALSGPSLAA  118 
CYP5619A1_      43  ATEKVVGFCGPEALKVFDANLRDGTFVRHGALPSGLNELLGAVLPTTDGDAHARKKKLVLAAFSGAQLAA  112 
CYP5619C1       55  VSEKIAGFCGPEMLSQYDAHVAAGHIVRENALPAGIVELLGPILATLDGDVHDSRKEAIMGAFSKEMLAS  124 
CYP5619B2_      58  VSEKIAGFCGPELLAAFDDKLRDGSIVREGAFPPGVLALLGPIMSTIDGEEHDARKAAALEALTPARLDL  127 
CYP5619B1_      53  VNEKIMGFCGPEALLAYDTQVKEGKIVRASAFPTGILELLGAVVSTLDDDAHAKRKAALLVAFTPEKLDA  122 
Consensus_aa:       ssE.lhGFCtPEhL.h@Ds.l.sG.lsRcsAhPsGll.LhGshhtTlDGp.@s.Rp.thL.Ahos..Lsh 
Consensus_ss:         eeeeee  hhhhhhhhhh  hhh       hhhhhhh    eee   hhhhhhhhhhhhhhhhhhhhh 
 
 
Conservation:       9 9 6   66 699 99969   996   6  69  66   69                9 666 6 
CYP5619D1_     119  YQPRIQRRIQEDHATWAARGSTFSLALYAKTSTFKVFLDVVYGIDDPEKY------TGHRAQLDEYLFYL  182 
CYP5619D2      119  YQPRIQQLIQDDHATWAARGGTFSLALQAKTTTFKVFLAVVYGVTQPDEY------VGYRAQLDEYLEYA  182 
CYP5619A1_     113  YKPLIRTTIQNEHAKWAAHGASMSLVANAKVLVFKLSLLLILGLED--NY------DNSRELLDTYMLAL  174 
CYP5619C1      125  YAPIVFEIVQKEHAAWAAHGGEISLALSCKKTVFKVFLAILYGITNLTPAEYDAKFDPFRDLLDSFIRAI  194 
CYP5619B2_     128  YAPIIREIVEAEHASWAARGGAISLACLTRDMVFRIFLKVLYGVER--HDG-----NKFRVLLDDFIVSI  190 
CYP5619B1_     123  YKPKIREIIQHDHAAWAARGGSLSLALSCKKMVFHVFMATLLGLENVD--------DEYRELVEAFVSSI  184 
Consensus_aa:       Y.P.Ipphlp.-HAsWAA+GtshSLAh.h+phhF+lFL.llhGlpp..p.......s.@R.bLDp@l..l 
Consensus_ss:       hhhhhhhhhhhhhhhhhhh   eehhhhhhhhhhhhhhhhhhhhh   hh      hhhhhhhhhhhhhh 
 
 
Conservation:         6   66  6   6       6 99 6 6 696    6 6   6  66    6   6  9 96 6 666 
CYP5619D1_     183  SKTSSRAPSDAAKIREHLLAAIVRPAIASSLARVRSGAPLTCVLDTVVAQGTVSEADLALESFQLLAMGL  252 
CYP5619D2      183  KKTLSRAPSDAIKIRDRLLATLVRPAIAASHARVRAGAAPTCVLDALVAQNTMSDSDLATEGFQLMAMGL  252 
CYP5619A1_     175  RNSVRRADPAGVRSRDELIRTMINPALATSHDRVHTGKPKPCALDHLVAAGVLSDDDLRAELFHLLCMSL  244 
CYP5619C1      195  PKSSKGADAEGLVCKQRLLDELVAPALAASQARVEAKAPVPCFLDYMLGQTELTPDVVHLEAFHALFAGL  264 
CYP5619B2_     191  RRSSKHADPHGVRCRTQILDELIRPAIANAQARASNKTPVPSVIDCLVANGKMTPDVLETEAFHFLFAGF  260 
CYP5619B1_     185  RKSARKPDTTGMDARTQVVEELIRPAVREAKARVAAQKPLPTVVEVLVADGRLSDEELNLELFHALFAGL  254 
Consensus_aa:       p+osp+AsspthchRppll.pllpPAlAstpARhps..P.sthlDhlVApsphosssL.hE.FphLhhGh 
Consensus_ss:       hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh    hhhhhhhhhh     hhhhhhhhhhhhh 
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Conservation:        9  666 6  99              9  6  99   6  9 96 69   6 6  9969 6 969   6 
CYP5619D1_     253  PGLEGLVVHTITAMVSLDDVRGQMATARDAYTAKYPGGA-FWSHLDDLDAVNQYVNEVQRVCGASPRHTF  321 
CYP5619D2      253  LGLEGLVVHTITAMVSVDGVRGQLGSARDAYVSKYPNGA-HWRHLDDLSVVNAYVNEVQRVYNASPRHTF  321 
CYP5619A1_     245  GGLECWVANCITAAASSTDVLAQLTAGRDAFITKYPAEADRWSHLGDLGYVNNYIQEVKRTYVAGPSHMY  314 
CYP5619C1      265  GGTQCLVVNTITALAQYPTVAEKVHASRAKFVIKY--HDDRWRHFDNLGYCNRFLLEVKRFYSAGPAQLF  332 
CYP5619B2_     261  GGVACLATNILTAVATHPSARKDLLDARAEYVTKY-DGDARWAHFHDLGYVNLFILEVKRFYVAGPTAVF  329 
CYP5619B1_     255  GGVTCLVINAVTACIELPAIREKVSAAREAFLAKYPNEDDRWSHFADLGYMHHFILEVKRFYVAGPTQLY  324 
Consensus_aa:       sGl.tLhhphlTAhhphssh..pl.stRs.@lhKY.s.s.+W.Hh.DLthhN.@l.EVpRhYsAtPp.h@ 
Consensus_ss:       hhhhhhhhhhhhhhhh hhhhhhhhhhhhhhh         hhhhh  hhhhhhhhhhhhh   hhhh 
 
 
Conservation:       6966 6       9     99  9  6 96  6  6 69  9  9 6 99             6 
CYP5619D1_     322  ARATKDFSVPSGSGATVAVPKNRLTVVLLDCINNDPKRWPSPEQFQPARF-----------AAANTS---  377 
CYP5619D2      322  ARATKDFVVTNSS----SVPKHSLTAALLDCLNYNAARWPSPAQFQVARF-----------AGANPS---  373 
CYP5619A1_     315  ARATKDTDVRTSEG-TFHVPKGCLVAAALDGTNKHPSVWANPTKFDPSRF-----------STAKVDM--  370 
CYP5619C1      333  GRTTQELTFTTPDG-EFAIPKGVLAVAGLDATNRHPDVWTDPSVFNPDRF-----------DNGFSEASD  390 
CYP5619B2_     330  GRTKTDLEIPTKNG-VYKLPKGCLAAAGLEATNRHPDVWTDPNLFNPNRFR----------DLGHVRTTK  388 
CYP5619B1_     325  GRATDDLEISTANG-SFKVPKGCLATAGLEVTSKHPDVWSDPHTFNPDRFAPQDASTTPVDPDAFKDGAR  393 
Consensus_aa:       tRhppDhplso.sG.sh.lPKssLhhA.L-thNpcPs.WssPp.FpPsRF...........s.t.sp... 
Consensus_ss:       eeeeeeeee       ee     eeeeehhh    hhh 
 
 
Conservation:                 66966        6 69  6 9 69699   999 99 6 6 9 9   9     69 9 6 
CYP5619D1_     378  -------AYGFAPFAIDDL--VHRAEGRREGLSRLILQSHVVSLLDFVAVMAPLQSFALGDG-VNPLPID  437 
CYP5619D2      374  -------AYEFAPFALNDL--VDRRAGRREGLSRLILQTHVVSLLDFAAVMAPLQSYALDDG-LNPLPVD  433 
CYP5619A1_     371  -------AFGFCPHAIGA---DRRCAG--EELSTLILQSFMVSLFDFMWKMLPHQDYTLDTTLVNPMPKG  428 
CYP5619C1      391  -------LYKLCPHAIGKTTGGRKCAG--RDLATLVLQASLVSLFDFKWTLVPNQDLSLEEGKSTPMPKG  451 
CYP5619B2_     389  -------PHAFCPHAFGESS-HRRCAG--EDLTTLILQSTVVSLYDFVWQMVPNQDYKLAVGSSTPTPVG  448 
CYP5619B1_     394  DVTAPDMMYKFCPHSIGI---ARRCAG--EGLTTLVLQCFVVSLFDFIWQMVPGQNYQLEEKSSTPTPIG  458 
Consensus_aa:       ........@.FtP@Ahs.....+RtAG..EsLopLlLQthlVSLhDFhh.MhP.Qs@.L..s.ssPhP.s 
Consensus_ss:                eeee                hhhhhhhhhhhhhhhhhhhhhh             ee 
 
 
Conservation:        96 669              66     69  9  9 99 6    6   6   9 969669669669  6 
CYP5619D1_     438  LLTTVSFRYVPG------VVQGD---IDAWRRLHHPSAKLYNGSLENPLLAASDKRLDFWTHSMIQLFNV  498 
CYP5619D2      434  LLTTVGFHYAPG------VAHSSNAYDDAWRRLRQPSAKLYNSSIESPL--SSDKRLDFLTHSMIQLLNV  495 
CYP5619A1_     429  GLMVVGFHRRTDLSASMVEVAGS---EEDWKFLSLPEAKVYRDDKEALHDMFADERLDLWTHLMLKLLAK  495 
CYP5619C1      452  LLMASSFTHRHSESETECDVA-------DWHLLNLPEAKALVGIAGTVSDDEDDARLDLWTRLMIKLIAK  514 
CYP5619B2_     449  QLMAVGFHRRTDDAVEIIGTVGS---KADWKFLNLPEAKELV---GTAMDLYDDARLDLWTRLMIKLIGK  512 
CYP5619B1_     459  QLMAVGFHRRTLDDVVTFGTAGS---DEDWHFLSLPQAKELVG-SGT-ADLYDDARMDLWTRLMIKLIGK  523 
Consensus_aa:       bLhhVtF+..ss......shhGS...c.sW+.LphPpAK.hss...ssh.h.sD.RLDhWT+.MIpLls. 
Consensus_ss:               hhhhhhhhh                     hhhhhhhhhhhhhhhhhhhh   hhhhhhh h 
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Conservation:       66  9  9 6   6  9  99 969 99 66 9 66669996   96      66969 696 969   9 
CYP5619D1_     499  RFETWVTPTAAASIKVPTTQKNLPKRTLYGTSIQIPTEDEDVA-IPKVILESAKLLQDTAPFVDNFDAKW  567 
CYP5619D2      496  RFATWVTPTAAASITVPKSQKPLAKQTLHGTSIQIPVDDEDVS-IPKVLLDGAKLLQDTAPFVDNFDDSW  564 
CYP5619A1_     496  KQSMWNKPFANQAITAPKYQKTLPKITLYGLKIQIPTEDEDWPSDPWNEVATVKFLRDSCPLGDDFEHTW  565 
CYP5619C1      515  KQARWNKPVANEVLTVPQFQKELPKMTLIQTNIQVATEDEDWPNQPWLEIQQSNFLRDYAPFVDNFEHTW  584 
CYP5619B2_     513  KQAVWDRPYANQILRIPQHQKPLPKITLIQTNIDIATEDEDWPNQPWLEIQQSNFLRDHAPFVDNFEHTW  582 
CYP5619B1_     524  KQATWDRPFVESCLTIPKHQKVLPKLTLIQTSIEIPTEDEDWPKQPWLEIKQSNFLRDHAPFIDDFKHTW  593 
Consensus_aa:       +bthWspPhAs..lplPphQKsLPKbTLh.TsIpIsTEDEDhs.bPblblpptphLpDhAPFlDsF-coW 
Consensus_ss:       hh     hhhhhhh   hhhhhhhhhhhh   hhhhhh              hhh         hhhh 
 
 
Conservation:        99999966969969 9999969996999999999966999699966 99  996999996  6 66  6 
CYP5619D1_     568  APGEDMEGCVLSKVGRMWPRVRVHWDDRYSDRALELLVFNGLGQHMVQKLATAHDDGSYYTVATNYLASI  637 
CYP5619D2      565  VPGEDMEGYVLSKVGRMWPRVRVHWDDRYSDRALELFVFNGLGQHMVTKLSAAHSDGSYYTATTSFLETL  634 
CYP5619A1_     566  LPGEDMERYVMSKVGSMWPRVNVHWNDRYSDRALELLVFNGLGQHLVTKLRTAHDDGSYYGICLDFMQAL  635 
CYP5619C1      585  LPGEDMERYVMSKVGSMWPRVNVHWNDRYSDRALELLAFNGFGQHLLTKLPEAHDDGSYYGICLNFLKGL  654 
CYP5619B2_     583  LPGEDMERYVMSKVGSMWPRVNVHWNDRYSDRALELLAFNGFGQHLLTKLPEAHDDGSYYGICLNFMKSL  652 
CYP5619B1_     594  LPGEDMERYVMSKLGHMWPRVNVHWNDRYSDRALELLAFNGLGQHLLMKLPEAHDDGSYYGICLDFMNVL  663 
Consensus_aa:       lPGEDME.YVhSKVGpMWPRVpVHWsDRYSDRALELLhFNGhGQHhlhKLspAHDDGSYYslthsFhpsL 
Consensus_ss:            hhhhhhhhhhhh         hhh  eeeeeee   eeeeehheee           hhhhh 
 
 
Conservation:       6996999 6999969   9999996966 6 69 6  969696999696  9699699969 9 9969 6 
CYP5619D1_     638  EVRTGYAITGADAFFDKNGKVTKIVRLGKTIRPIDASWEYVKMCFRSSLVSKITAVDHLIGLHVTVGNYM  707 
CYP5619D2      635  DVRPGYAVTGADAYFDKNGKVTKIVRLGKTFRPADAQWEYVKMCFRSSVANKVTAVDHLIGLHVTVGNYM  704 
CYP5619A1_     636  DVRPGYAKYGADAYFNAKGKVTKIVRLGKTVHPGDEDWEYAKLCFRGSLQTKVTALDHLLGIHITVANGL  705 
CYP5619C1      655  EVRPGYAKYGADAFFSAEGKVTKIVRGDVTVRPGDDNWAYAKLCFRGSLQTKITAVDHLLGVHATVANIM  724 
CYP5619B2_     653  EVRPGYAKYGADAFFTSKGKVTKIIRGDIASRPGDSGWEYAKLCFRGSLQTKVTAVDHLLGIHATVANIM  722 
CYP5619B1_     664  EVRPGYAKYGADAYFTAKGKVTKIIRGGVTSRPGEDGWEYAKLCFRGSLQTKVTAVDHLLGIHATVANYM  733 
Consensus_aa:       -VRPGYAbhGADA@Fs.pGKVTKIlR.s.h.RPtDssWEYhKhCFRtSL.oKlTAVDHLlGlHhTVtNhM 
Consensus_ss:             eeeeeee         eeeee        hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh 
 
 
Conservation:       6   99999969969996999999666996 96  99699969699  66 6966696  66  666969 
CYP5619D1_     708  TTGSREQLPPTHPLRRLIKPFTFRAVAINYDASIALFAPKGMLHRAFPYTEKGLKDTWAMALKSLTLEPF  777 
CYP5619D2      705  TTASREQLPPTHPLRRLIKPFTFRAVAINYEASKLLFAPKGILHRAHPYSEKGLKDTWAMALQSLKLEPF  774 
CYP5619A1_     706  VTSTREQLPPTHPLRRLLKPFTFRSVIINYNASYALFWPKGMLHRAFSLSVEGMQQTWELGLANFKYETF  775 
CYP5619C1      725  VIANREQLPPTHPLRRLIKPFTFRSIAINYGAGRALFWPKGMLQRAYALTDKGMKQTWDIGLANFKYETF  794 
CYP5619B2_     723  VVANREQLPPTHPLRRLIKPFTFRSVAINYGAGRALFWPKGMLQRAYALTDKGMKQTTQDAPAH------  786 
CYP5619B1_     734  VTSIREQLPPAHPVRRLLKPFTFRSVAINFGAGRSLFWPKGMLQRAYALTDKGMKQTWEYGLANFKYETF  803 
Consensus_aa:       hhtsREQLPPTHPLRRLlKPFTFRtVAINYsAt.tLFhPKGMLpRA@sho-KGhKpTh..t..phKhEsF 
Consensus_ss:       hhhhh       hhhhhhhhhhhhhhhhhhhhhhhh     eeeeee   hhhhhhhhhhh 
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Conservation:       966 999 699 69969999 669 969 9   9 6999 6 6    9    669 69   9     6 9 
CYP5619D1_     778  PVHLARQQVDTITLPYHEDGADYWEIVRTFVSEYLDLYYTSNDDVTHDVSIQALWTFLNKQLP-TPLGVL  846 
CYP5619D2      775  PVHMARQNIDTLKLPFHEDGMDFWTIVRGFTGEYLNLYYESDEDVTRDASTQAFWAFLDKQLP-TPLGAL  843 
CYP5619A1_     776  PEHKARQNIDTTTLPYHEDGMDFWLIVRGFVGSYIDLYYPCDESLTQDTAVQAFWSYLKTTLPPNSIRPL  845 
CYP5619C1      795  PEHIARQNIDTTTLPFHEDGMDYWHICRSFVSNYVDLYYKSEDALQNDTDVHAFWTFLSTKL-PVPMRTL  863 
CYP5619B2_          ---------------------------------------------------------------------- 
CYP5619B1_     804  PERKARQSIDTVTLPFHEDGIEYWQICRTFANDYVDLYYKSEDATSADADLKRFWTFLDEKL-PFTMRPL  872 
Consensus_aa:       P.+bARQsIDThTLP@HEDGh-@W.IhRsFhspYlDLYY.t--shp.Dhslp.FWo@LpppL...sh.sL 
Consensus_ss:       hhhhhh         hhhhhhhhhhhhhhhhhhhhhhh   hhhhh  hhhhhhhhhhhh 
 
 
Conservation:        6666996699 99996669999969999999999996699999969996  99 9999 6996 99 9 
CYP5619D1_     847  SLDNLKDVVAHSIFLVTAMHNHLGGIAEYVSDPAFCPVSWVEGELSGRPGNAVRAALIMSGTGFPQPNIL  916 
CYP5619D2      844  SLESLKDVVAHGIFLVTAMHNHLGGIAEYVSDPAFCPVSWVEGELAGRPGAAVRTALIMSGTGYPQPSIL  913 
CYP5619A1_     846  SKDNIKDFVAHAIFLVSSMHNHLGTIAEYVSDPAFCPSAWVEGELAGRPGPCVRGALIMAATGFVQPSIK  915 
CYP5619C1      864  TLENLKDFVAHFIFLVSSMHNHLGTIAEYVSDPAFCPSAWVEGELAGRPSTGVRLALIMTATGFAQPAIT  933 
CYP5619B2_     787  ------------------RHN-------------------------------------------------  789 
CYP5619B1_     873  NLENLKDFLAHGIFLVSSMHNHLGTIAEYVSDPAFCPSAWVEGELAGRPGTGVRLALIMTATGFTQPDIT  942 
Consensus_aa:       sb-NlKDhlAH.IFLVot.HNHLGsIAEYVSDPAFCPstWVEGELAGRPtstVR.ALIMstTGFsQPsI. 
Consensus_ss:        hhhhhhhhhhhhhh  hhhhh                             hhhhhhhhhhhhhh 
 
 
Conservation:       99999 6999996696  996 6 6   9966996 9  969 999 69699669 
CYP5619D1_     917  EDFSHVLLDDAAKAVAHRFTASLQAFVHVVEARNAQRIHPYQAFNPAVMDMAIGI  971 
CYP5619D2      914  EDFSHVLLDDAAKAVAHRFTTSLQSFVMVVEARNAQRVLPYQGFNPAVMDMAIGI  968 
CYP5619A1_     916  EDFSHIMLDDAAKAVCRKFTADVCAYAAVVEGRNTKRQHPYQAFNPNTMEMAVSI  970 
CYP5619C1      934  EDFSHIMLDDAAKAVCQAFTAAVTAQIAVVDARNATRVQPFQSFNPKTMEMAVSI  988 
CYP5619B2_     790  ---------DAAVP-----------------------------------------  794 
CYP5619B1_     943  EDFSHLMLDDAAKAVCKAFTAAVIAQIAVVDARNATRVQPFQSFNPKTMEMAVSI  997 
Consensus_aa:       EDFSHlhLDDAA.sVtp.FTAsl.AbhhVV-tRNhpR.pP@QtFNP.hM-MAltI 
Consensus_ss:         hhhh   hhhhhhhhhhhhhhhhhhhhhhhh       eee 
 
Figure 2.4. Structural alignment of CYP5619 family members from S. diclina using PROMALS3D (Pie et al., 2008). P450 characteristic 
notations for α-helices (shown in red) and β-strands (shown in blue) were mapped. Residues highlighted in green appear in contact with the 
heme. The absolutely conserved ExxR motif is highlighted in cyan, as well as the amino acids matching the P450 heme signature consensus 
sequence according to the PROSITE database. The cysteine residue responsible for the co-ordination of heme iron is highlighted in cyan.
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2.4. Conclusion 
In conclusion, in this chapter phylogenetic and secondary structure analysis of CYP5619 P450 
family members was carried out. Phylogenetic analysis revealed the presence of the CYP5619 
family in other oomycetes and in phytoplankton. Secondary structure analysis revealed 
conservation of P450 characteristic motifs in all CYP5619 family members with the exception 
of CYP5619D members missing Cysteine in the CxG motif. The identified CYP5619 P450s 
in other oomycetes and phytoplankton will be submitted for naming to International P450 
Nomenclature Committee headed by Prof DR Nelson, University of Tennessee, USA.   
 
  
© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
59 | P a g e  
 
References 
 Brodhun, F., Göbel, C., Hornung, E. and Feussner, I., 2009. Identification of PpoA 
from Aspergillus nidulans as a fusion protein of a fatty acid heme 
dioxygenase/peroxidase and a cytochrome P450. Journal of Biological Chemistry, 
284(18), pp. 11792-11805. 
 Chen, J.K., Wang, D.W., Falck, J.R., Capdevila, J. and Harris, R.C., 1999. 
Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates 
that 14, 15-epoxyeicosatrienoic acid functions as an intracellular second messenger in 
response to epidermal growth factor. Journal of Biological Chemistry, 274(8), pp. 
4764-4769. 
 Graham, S.E. and Peterson, J.A., 1999. How similar are P450s and what can their 
differences teach us? Archives of Biochemistry and Biophysics, 369(1), pp. 24-29. 
 Graham-Lorence, S., Truan, G., Peterson, J.A., Falck, J.R., Wei, S., Helvig, C. and 
Capdevila, J.H., 1997. An active site substitution, F87V, converts cytochrome P450 
BM-3 into a regio-and stereoselective (14S, 15R)-arachidonic acid epoxygenase. 
Journal of Biological Chemistry, 272(2), pp. 1127-1135. 
 Guengerich, F.P. and Munro, A.W., 2013. Unusual cytochrome P450 enzymes and 
reactions. Journal of Biological Chemistry, 288(24), pp. 17065-17073. 
 Haas, B.J., Kamoun, S., Zody, M.C., Jiang, R.H., Handsaker, R.E., Cano, L.M., 
Grabherr, M., Kodira, C.D., Raffaele, S., Torto-Alalibo, T. and Bozkurt, T.O., 2009. 
Genome sequence and analysis of the Irish potato famine pathogen Phytophthora 
infestans. Nature, 461(7262), pp. 393-398. 
 Hannemann, F., Bichet, A., Ewen, K.M. and Bernhardt, R., 2007. Cytochrome P450 
systems — biological variations of electron transport chains. Biochimica et Biophysica 
Acta (BBA) - General Subjects, 1770(3), pp. 330-344. 
© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
60 | P a g e  
 
 Hansen, B.G., Mnich, E., Nielsen, K.F., Nielsen, J.B., Nielsen, M.T., Mortensen, 
U.H., Larsen, T.O. and Patil, K.R., 2012. Involvement of a natural fusion of a 
cytochrome P450 and a hydrolase in mycophenolic acid biosynthesis. Applied and 
Environmental Microbiology, 78(14), pp. 4908-4913. 
 Hawkes, D.B., Slessor, K.E., Bernhardt, P.V. and De Voss, J.J., 2010. Cloning, 
expression and purification of cindoxin, an unusual Fmn‐containing cytochrome P450 
redox partner. ChemBioChem, 11(8), pp. 1107-1114. 
 Jackson, C.J., Lamb, D.C., Marczylo, T.H., Warrilow, A.G., Manning, N.J., Lowe, 
D.J., Kelly, D.E. and Kelly, S.L., 2002. A novel sterol 14α-demethylase/ferredoxin 
fusion protein (MCCYP51FX) from Methylococcus capsulatus represents a new class 
of the cytochrome P450 superfamily. Journal of Biological Chemistry, 277(49), pp. 
46959-46965. 
 Jawallapersand, P., Mashele, S.S., Kovačič, L., Stojan, J., Komel, R., Pakala, S.B., 
Kraševec, N. and Syed, K., 2014. Cytochrome P450 monooxygenase CYP53 family in 
fungi: Comparative structural and evolutionary analysis and its role as a common 
alternative anti-fungal drug target. PloS one, 9(9), p. e107209. 
 Kelly, S.L. and Kelly, D.E., 2013. Microbial cytochromes P450: Biodiversity and 
biotechnology. Where do cytochromes P450 come from, what do they do and what 
can they do for us? Phil. Trans. R. Soc. B, 368(1612), p. 20120476. 
 Lawson, R.J., von Wachenfeldt, C., Haq, I., Perkins, J. and Munro, A.W., 2004. 
Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, 
YkuN and YkuP: Biophysical properties and interactions with cytochrome P450. BioI. 
Biochemistry, 43(39), pp. 12390-12409. 
 Marchler-Bauer, A., Lu, S., Anderson, J.B., Chitsaz, F., Derbyshire, M.K., DeWeese-
Scott, C., Fong, J.H., Geer, L.Y., Geer, R.C., Gonzales, N.R. and Gwadz, M., 2010. 
© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
61 | P a g e  
 
CDD: A conserved domain database for the functional annotation of proteins. Nucleic 
Acids Research, 39(suppl_1), pp. D225-D229. 
 Marchler-Bauer, A., Derbyshire, M.K., Gonzales, N.R., Lu, S., Chitsaz, F., Geer, L.Y., 
Geer, R.C., He, J., Gwadz, M., Hurwitz, D.I. and Lanczycki, C.J., 2014. CDD: NCBI's 
conserved domain database. Nucleic Acids Research, 43(D1), pp. D222-D226. 
 Moncrieffe, M.C., Fernandez, M.J., Spiteller, D., Matsumura, H., Gay, N.J., Luisi, 
B.F. and Leadlay, P.F., 2012. Structure of the glycosyltransferase EryCIII in complex 
with its activating P450 homologue EryCII. Journal of Molecular Biology, 415(1), 
pp.92-101. 
 Munro, A.W., Leys, D.G., McLean, K.J., Marshall, K.R., Ost, T.W., Daff, S., Miles, 
C.S., Chapman, S.K., Lysek, D.A., Moser, C.C. and Page, C.C., 2002. P450 BM3: The 
very model of a modern flavocytochrome. Trends in Biochemical Sciences, 27(5), pp. 
250-257. 
 Munro, A.W., Girvan, H.M. and McLean, K.J., 2007. Variations on a (t) heme —
Novel mechanisms, redox partners and catalytic functions in the cytochrome P450 
superfamily. Natural Product Reports, 24(3), pp. 585-609. 
 Nei, M. and Kumar, S., 2000. Molecular evolution and phylogenetics. Oxford 
University Press. 
 Phillips, A.J., Anderson, V.L., Robertson, E.J., Secombes, C.J. and van West, P., 
2008. New insights into animal pathogenic oomycetes. Trends in Microbiology, 16(1), 
pp. 13-19. 
 Pie, J., Kim, B.H. and Grishin, N.V., 2008. PROMALS3D: A tool for multiple 
sequence and structure alignment. Nucleic Acids Res, 36(7), pp. 2295-300. 
 Rylott, E.L., Jackson, R.G., Sabbadin, F., Seth-Smith, H.M., Edwards, J., Chong, C.S., 
Strand, S.E., Grogan, G. and Bruce, N.C., 2011. The explosive-degrading cytochrome 
© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
62 | P a g e  
 
P450 XplA: Biochemistry, structural features and prospects for bioremediation. 
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1814(1), pp. 230-
236. 
 Saitou, N. and Nei, M., 1987. The neighbor-joining method: A new method for 
reconstructing phylogenetic trees. Molecular Biology and Evolution, 4(4), pp. 406-
425. 
 Sello, M.M., Jafta, N., Nelson, D.R., Chen, W., Yu, J.H., Parvez, M., Kgosiemang, 
I.K.R., Monyaki, R., Raselemane, S.C., Qhanya, L.B. and Mthakathi, N.T., 2015. 
Diversity and evolution of cytochrome P450 monooxygenases in Oomycetes. 
Scientific Reports, 5, p. 11572. 
 Sirim, D., Widmann, M., Wagner, F. and Pleiss, J., 2010. Prediction and analysis of 
the modular structure of cytochrome P450 monooxygenases. BMC Structural Biology, 
10(1), p. 34. 
 Syed, K., Shale, K., Pagadala, N.S. and Tuszynski, J., 2014a. Systematic identification 
and evolutionary analysis of catalytically versatile cytochrome P450 monooxygenase 
families enriched in model basidiomycete fungi. PLoS One, 9(1), p. e86683. 
 Syed, K., Shale, K., Nazir, K.N.H., Krasevec, N., Mashele, S.S. and Pagadala, N.S., 
2014b. Genome-wide identification, annotation and characterization of novel 
thermostable cytochrome P450 monooxygenases from the thermophilic biomass-
degrading fungi Thielavia terrestris and Myceliophthora thermophila. Genes and 
Genomics, 36(3), pp. 321-333. 
 Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M. and Kumar, S., 2011. 
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, 
evolutionary distance, and maximum parsimony methods. Molecular Biology and 
Evolution, 28(10), pp. 2731-2739. 
© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
63 | P a g e  
 
 Urlacher, V.B. and Eiben, S., 2006. Cytochrome P450 monooxygenases: Perspectives 
for synthetic application. Trends in Biotechnology, 24(7), pp. 324-330. 
 Warman, A.J., Robinson, J.W., Luciakova, D., Lawrence, A.D., Marshall, K.R., 
Warren, M.J., Cheesman, M.R., Rigby, S.E., Munro, A.W. and McLean, K.J., 2012. 
Characterization of Cupriavidus metallidurans CYP116B1 – A thiocarbamate 
herbicide oxygenating P450–phthalate dioxygenase reductase fusion protein. The 
FEBS Journal, 279(9), pp. 1675-1693. 
 Wass, M.N., Kelley, L.A. and Sternberg, M.J., 2010. 3DLigandSite: Predicting ligand-
binding sites using similar structures. Nucleic Acids Research, 38(suppl_2), pp. W469-
W473. 
  
© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
64 | P a g e  
 
APPENDIX 
CYP5619 family member sequences along with CYP51 of Sacchaaromyces cerevisiae (used as an out 
group). 
 



































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 









































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
73 | P a g e  
 







































© Central University of Technology, Free State
CHAPTER 2: PHYLOGENETIC AND SECONDARY STRUCTURE ANALYSIS OF NOVEL P450 FAMILY CYP5619 FROM 
SAPROLEGNIA DICLINA 
 
74 | P a g e  
 























© Central University of Technology, Free State
CHAPTER 3: IN SILICO STRUCTURAL AND FUNCTIONAL ANALYSIS OF NO VEL P450 -FUSIO N PRO TEIN CYP5619A1 
FRO M SAPRO LEGNIA DICLINA 
 
75 | P a g e  
 
CHAPTER 3 
IN SILICO STRUCTURAL AND FUNCTIONAL ANALYSIS OF NOVEL P450-
FUSION PROTEIN CYP5619A1 FROM SAPROLEGNIA DICLINA  
3.1. Introduction 
Cytochrome P450 monooxygenases (CYPs or P450s) form a very divergent family, with highly 
variable sequences. They catalyse a wide variety of oxidative reactions and are therefore of 
great relevance in drug development and biotechnological applications (Urlacher & Eiben, 
2006; Bernhardt, 2006, 2013). Despite their differences in sequence and substrate specific ity, 
the structures of P450s are highly similar. They all share a common fold and conserved catalytic 
machinery (Graham & Peterson, 1999; Sirim et al., 2010). Genome-wide identification and 
annotation of P450s revealed the presence of a moderate number of P450s in the genome of 13 
oomycetes belonging to two different classes and three different orders and led to the discovery 
of a novel P450 family, CYP5619 (Sello et al., 2015). The novel P450 family members are 
fusion proteins found in Saprolegnia diclina, a fish pathogen, with an N-terminal P450 domain 
fused to a heme-dioxygenase/peroxidase domain at the C-terminal. In order to use this novel 
P450 as drug target, it is necessary to predict its structure, which would consequently enable 
researchers to screen for potential inhibitors.  
 Protein structure prediction is the evaluation of a protein that results in the elaboration 
of a three-dimensional structure of that protein, based on its amino acid sequence. In other 
words, one predicts the folding and the secondary, tertiary, and quaternary (if applicable) 
structures of the protein from its primary structure. This is one of the most important goals 
pursued in bioinformatics and theoretical chemistry and it is fundamentally different from the 
inverse problem of protein design. The importance of protein structure prediction tools is well 
demonstrated in medicine and pharmacy (for example, in drug design) and in biotechnology 
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(for example, in the design of novel enzymes) (Dunbrack et al., 2000). Proteins are chains of 
amino acids linked by peptide bonds. The chain’s ability to rotate around each carbon-α atom 
allows a multitude of conformations. Predicting the structure of the protein occurs through 
determining secondary structures and assigning them as α-helices, β-strands, and turns (loops 
and coils), which form the overall three-dimensional configuration of the chain. This is 
achieved by using a set of techniques in bioinformatics (Dubey, 2014). 
 The bends and folds of the secondary structures of the polypeptide chain determine the 
tertiary structure of the protein, which is necessary for it to assume its function. In some cases 
where there are more than one polypeptide, a quaternary structure is required in order for the 
proteins to assume their biological function. Examples of this type of conformation include 
those of haemoglobin, deoxyribonucleic acid (DNA) polymerase and ion channels (Clugston, 
2000; Dubey, 2014). A set of methods is followed for the prediction of the tertiary structure of 
proteins, including ab initio or de-novo protein modeling (Hardin et al., 2002), comparative 
protein modeling (Sánchez & Šali, 2002), side-chain geometry prediction (Keating et al., 2001) 
and statistical prediction of structural classes (Metfessel et al., 1993). Nonetheless, protein 
structure prediction remains an extremely difficult and unresolved undertaking, the two main 
problems being calculating the protein free energy and finding the global minimum of that 
energy. A protein structure prediction method must explore the space of possible protein 
structures, which is astronomically large (Perdomo-Ortiz et al., 2012). These problems must 
explicitly be resolved when using the ab initio or de novo protein structure prediction. On the 
other hand, they can be partially bypassed in comparative or homology modeling and fold 
recognition methods, in which the search space is pruned by the assumption that the protein in 
question adopts a structure that is close to the experimentally determined structure of another 
homologous protein (Fiser, 2010). The progress and challenges in protein structure prediction 
have been reviewed by Zhang (2008). 
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 The method used in this study is that of homology modeling, and it is based on the 
observation that the protein tertiary structure is better conserved than the amino acid sequence 
(Marti-Renom et al., 2000). Because a protein's fold is more evolutionarily conserved than its 
amino acid sequence, a target sequence can be modeled with reasonable accuracy on a very 
distantly related template, provided that the relationship between target and template can be 
discerned through sequence alignment. The procedure can be fragmented into four major steps, 
namely template selection, target-template alignment, model construction and model 
assessment. 
This chapter aims to employ bioinformatics tools to understand the structural and 
functional aspects of the novel P450 family member, CYP5619A1, from the deadliest aquatic 
pathogen S. diclina. Functional analysis of CYP5619A1 is carried out with different predicted 
substrates based on homolog protein with the same motifs found in fungi (Brodhun et al., 2009) 
to identify possible substrates based on binding affinity.  
3.2. Methodology 
3.2.1. Homology modeling and validation 
The amino acid sequence of CYP5619A1 was retrieved from the database mentioned in the 
literature (Sello et al., 2015) and was aligned against protein structures deposited in Brookhaven 
Protein Data Bank (PDB) using the protein-protein BLASTp. Alternatively, the Molecular 
Operating Environment (MOE, 2016) was used to predict the best homolog template for 
CYP5619A1, for comparison purposes. The crystal structure of retinoic acid-bound CYP120A1 
was used as template, since its structure was determined by both methods described earlier, to 
be the closest to CYP5619A1 in terms of primary sequence identity. Homology modeling of 
CYP5619A1 was performed using a restrained-based approach implemented in MOE. The 
amino acid sequence of CYP5619A1 was aligned with that of CYP120A1. A set of 10 models 
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was constructed for the target enzyme. The coordinates of the heme in the model were obtained 
from the crystal structure of CYP120A1 and the homology model was constructed along with 
those coordinates. The resulting three-dimensional models were optimised and a final model 
was obtained. The structure was validated with the Protein Structure Analysis (ProSA-web) 
tool (Sippl, 1993; Wiederstein & Sippl, 2007), ERRAT (Colovos & Yeates, 1993) and the 
VERIFY 3D program (Bowie et al., 1991; Lüthy et al., 1992) on the Structural Analysis and 
Verification Server (SAVES) (http://nihserver.mbi.ucla.edu/SAVES).  
3.2.2. Binding site analysis 
The software MOE was used on the final model, to assess the binding sites. A set of sites were 
found to be likely to bind with substrates. The site with more residues, which appeared to 
contain the heme group, was selected for docking studies. 
3.2.3. Ligand database 
Three-dimensional structures of fatty acids of different lengths and saturation states alongside 
the organic compound malachite green (MGR), shown in table 3.1, were obtained from 
PDBeChem: Ligand Dictionary at www.ebi.ac.uk/pdbe-srv/pdbechem/PDBEntry and used in 
the docking of the target model.  
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Table 3.1. Substrates used for docking (obtained from PDBeChem: Ligand Dictionary at 
www.ebi.ac.uk/pdbe-srv/pdbechem/PDBEntry).  
Saturated fatty acids Unsaturated fatty acids 
C14:0 Myristic acid 
 
C14:1 Δ9Z Myristoleic acid 
 
C16:0 Palmitic acid 
 
C16:1 Δ9Z Palmitoleic acid 
 
C18:0 Stearic acid C18:1 Δ9Z Oleic acid 
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C20:0 Icosanoic acid  
 
C18:2 Δ9Z,12Z  Linoleic acid 
 






C20:4 Δ5Z,8Z,11Z,14Z  Arachidonic acid 
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3.2.4. Molecular docking 
The CYP5619A1 model was prepared for docking in MOE and AutoDockTools 1.5.6 (Goodsell 
& Olson, 1990). MOE was used to correct the protonation and remove the solvent. The different 
ligands were all prepared for docking in AutoDockTools, following the same steps as the target 
protein: protonation, addition of charges, merging of non-polar H+ and assignment of atom 
types. Partial charges of ligands and protein were generated using the Gasteiger method with 
the aid of AutoDockTools. Non-polar hydrogens were merged and atom types were assigned. 
A cubic grid having 60 × 60 × 60 grid points per side and spacing of 0.375 Å was set, which 
corresponds to the substrate recognition site of the target P450 model. The grid was positioned 
onto the substrate access channel extending into the binding pocket of the model. Affinity maps 
of the grid were calculated using the AutoGrid program. The AutoDock 4.0 program was used 
to dock 12 ligands into the active-site cavity of the target model using the Lamarckian genetic 
algorithm, consisting of 200 runs and 270 000 generations, with the maximum number of 
energy evaluations set to 2.5 × 106. The resulting docked conformations within 2.0 Å root mean 
square deviation (RMSD) tolerance were clustered and analysed using AutoDockTools. 
Conformations with the lowest interaction energy and closest interaction to heme iron were 
selected for each ligand and rendered. 
3.3. Results and discussion 
3.3.1. Sequence alignment 
The sequence alignment of CYP5619A1 and the template 2VE3 obtained from BLASTp result 
has been carried out. The alignment (Figure 3.1) shows a highly conserved secondary structure 
despite being poorly conserved at amino acid sequence level.  
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3.3.2. Structural analysis of CYP5619A1 
Multiple sequence alignment of CYP5619A1 with CYP120A1 demonstrated that the two  
proteins are poorly homologous (28%), which was confirmed by the BLASTp homology search 
using the S. diclina CYP5619A1 sequence against the PDB database. Nevertheless, this is 
comprehensible, since CYP5619A1 from S. diclina belongs to a novel protein family that has 
not yet been characterised. The template for homology modeling of CYP5619A1 is the crystal 
structures of substrate-free and all-trans-retinoic acid-bound CYP120A1 from Synechocystis 
sp. PCC 6803, the first structural characterisation of a cyanobacterial P450, which was 
determined at 2.4 and 2.1 Å resolution, respectively (Kuhnel et al., 2008). 
The resulting modeled enzyme is a monomer, folded into a α/β domain consisting of a 
seven-stranded β-sheet and 14 α-helices (Figure 3.1 and 3.2). The β-sheet tends to form the 
hydrophobic substrate channel. The residues in the Glu287-Arg290 (EXXR) motif are found in 
the K helix. Literature suggested that they might be involved in stabilising the core structure of 
the protein and are on the proximal side of the heme (Graham & Peterson, 1999). Furthermore, 
the heme (displayed in sticks in Figure 3.2) is bound to the absolutely conserved cysteine at 
position 371, which is the fifth ligand of the heme iron, and the reason for the typical 450 nm 
soret absorbance found in CO-bound P450s (Omura & Sato, 1962). 
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Figure 3.1. Sequence alignment of protein CYP5619A1 with template CYP120A1 (PDB 
ID: 2VE3). Red rectangles represent α-helices, blue rectangles represent β-sheets. The Cys-
pocket is shown in a blue rectangle. Conserved residues are highlighted in green. 
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Figure 3.2. Homology model of CYP5619A1 with heme prosthetic group. Secondary 
structures are displayed in red (helices), yellow (sheets) and blue (coils and turns). The heme 
prosthetic group is shown in sticks at the center of the molecule with the iron as green ball. 
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Homology modeling usually results in the production of protein models with quite 
unfavourable bond lengths, bond angles, torsion angles and contacts. In that case, it is essential 
to minimise the energy in order to regularise local bond and angle geometry, and to relax close 
contacts in the geometric chain. The model of CYP5619A1 from S. diclina was optimised using 
the tleap and sander programs of the AMBER suite. Sander is the main simulation engine of 
the entire suite; it takes two input files describing the molecular system to be simulated ; one 
control file specifies the conditions of the simulation and computes a classical molecular 
dynamics trajectory based on this information. tleap is the helper program that takes 
predetermined coordinate files such as pdb and generates a topology file and a restart file, to 
feed to sander. Energy minimisation was performed to minimise stearic collisions and strains 
without significantly altering the overall structure. Energy computations and minimisation were 
carried out using the Amber14 force field. After optimisation the 3D model of CYP5619A1 
was verified using ProSA-web (Sippl, 1993; Wiederstein & Sippl, 2007), as well as the ERRAT 
(Colovos & Yeates, 1993) and VERIFY 3D (Bowie et al., 1991; Lüthy et al., 1992) programs 
available from the Structural Analysis and Verification Server (SAVES) 
(http://nihserver.mbi.ucla.edu/SAVES). ProSA-web was used to calculate the Z-score, while 
the Verify3D program analysed the compatibility of an atomic model (3D) with its own amino 
acid sequence (1D) to assess the 3D protein structure. ERRAT verifies crystallography-
determined protein structures and plots error values as a function of the position of a sliding 
nine-residue window, based on the statistics of non-bonded atom-atom interactions in the 
reported structure (compared to a database of reliable high-resolution structures). Validation 
results are displayed in Figures 3.3 to 3.5. 
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Figure 3.3. Z-score estimation for CYP5619A1 refined model on the ProSA-web server. 
The z-score of the modeled protein (-7.61) is represented as a black dot.  
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CYP5619A1 from S. diclina had a z-score of -7.61, indicating a good overall model 
quality. The score is represented by a dot displayed in a plot that contains the z-scores of all 
experimentally determined protein chains in current PDB (Figure 3.3). In the plot, groups of 
structures from X-ray crystallography and NMR are displayed in dark and light blue 
respectively and serve as a basis for comparison with the modeled protein. As shown, the z-
score of the input structure (that of CYP5619A1) is within the range of scores typically found 
for native proteins of similar size. 
ERRAT has been termed an “overall quality factor” for non-bonded atomic interactions, 
with higher scores indicating higher quality. The generally accepted range is >95 for a high-
quality model. For the current 3D model, the overall quality factor predicted by the ERRAT 
server was 96.226 (Figure 3.5). The Verify 3D server predicted that 86.36% of the residues in 
CYP5619A1 would have an average 3D-1D score > 0.2 (Figure 3.4), thereby confirming the 
good quality of the model, since the minimum percentage for good quality is 80. 
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Figure 3.4. Verify 3D result for CYP5619A1 refined model. 86.36% of the residues had an averaged 3D-1D score ≥ 0.2.  Pass: At least 80% of 
the amino acids scored ≥ 0.2 in the 3D/1D profile. 
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Figure 3.5. ERRAT result for CYP5619A1 refined model.  
*On the error axis, two lines are drawn to indicate the confidence with which it is possible to reject regions that exceed that error value. 
**Expressed as the percentage of the protein for which the calculated error value falls below the 95% rejection limit. Good high-resolution 
structures generally produce values around 95% or higher. For lower resolutions (2.5 to 3 Å), the average overall quality factor is around 91%. 
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3.3.3. Model-template superimposition 
For more assurance on the quality of the model, the structures of CYP5619A1 and CYP120A1 
were superimposed and compared based on the distance between their Cα backbones. The two 
superimposed structures have been coloured by RMSD and are displayed in Figure 3.6 below. 
 The green colour indicates a very narrow gap between the two structures, while 
lime-green and white colours indicate a wide gap and a total mismatch between the query 
sequence and the template, respectively. Mismatches are observed particularly around loops 
and also at the template structure’s N- and C- termini, which are observed in the alignment 
(Figure 3.1) protruding from the CYP5619A1 sequence. 
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Figure 3.6. Superimposed structures of the target protein CYP5619A1 and its template  
CYP102A1 (PDB ID: 2VE3). A) The superimposed structures are displayed in blue 
(CYP5619A1) and orange (CYP102A1). B) The superimposed structures are coloured by 
RMSD, with the green colour indicating close proximity between α-carbons. C) RSMD 
calculation; the overall RMSD is 0.951 Å. D) RMSD plot of all aligned residues showing only 
a few aligned residues with RMSD over 2 Å. 
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3.3.4. Active site mapping 
After the final model had been obtained and its quality confirmed, different potential binding 
sites of CYP5619A1 were searched using MOE, and structural comparison of the template and 
the model was done. In this study, the sites were searched in order to determine the protein 
active sites and binding sites by locating cavities in the CYP5619A1 structure that will allow 
access to the heme group. When the search was complete, the largest site was automatica l ly 
displayed on the structure, as shown in Figure 3.7.  
 Furthermore, the binding pocket was viewed and displayed (Figure 3.8). As shown in 
the Figure 3.8, the heme is in the core of the pocket, which appears to be highly hydrophobic, 
suggesting a very high affinity with the docked fatty acids, as shown in the docking results in 
the following section (Figure 3.21) 
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Figure 3.7. Active site cavity of CYP5619A1. Secondary structures are displayed in red 
(helices), yellow (sheets) and blue (coils and turns). The active site cavity is shown with the 
substrate access channel in grey (hydrophobic site) and red (hydrophilic site) spheres.  
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Figure 3.8. Active site view of the binding pocket of CYP5619A1. A) The pocket is displayed 
with MOE ActiveLP colour coding (Blue: mild polar; Green: Hydrophobic; H-Bonding: Pink) 
and shows a pattern of high hydrophobicity. B) Residues forming the pocket are labelled.  
Secondary structures in A and B are displayed in red (helices), yellow (sheets) and blue (coils 
and turns). The heme prosthetic group appears at the centre of the active site in grey sticks. 
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3.3.5. Substrate binding analysis 
The docking of model CYP5619A1 with 12 ligands (predicted substrates): myristic acid 
(MYR), palmitic acid (PLM), stearic acid (STE), icosanoic acid (DCR), myristoleic acid 
(MYZ), palmitoleic acid (PAM), oleic acid (OLE), linoleic acid (EIC), alpha-linolenic acid 
(LNL), arachidonic acid (ACD), eicosapentaenoic acid (EPA) and MGR, was performed with 
AutoDockTools. The 11 ligands were selected as possible substrates for CYP5619A1 based on 
homolog protein with the same motif found in fungi (Brodhun et al., 2009). The best results 
were selected according to the output clustering histogram and thus the lowest binding energies. 
The representative conformation for each cluster was chosen as the best pose for each ligand 
and was viewed in AutoDockTools. Interactions between residues are displayed in Figures 3.9 
to 3.20.  
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Figure 3.9. Interaction of myristic acid with CYP5619A1 model. The ligand is displayed in 
thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.10. Interaction of palmitic acid with CYP5619A1 model. The ligand is displayed 
in thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.11. Interaction of stearic acid with CYP5619A1 model. The ligand is displayed in 
thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.12. Interaction of icosanoic acid with CYP5619A1 model. The ligand is displayed 
in thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.13. Interaction of myristoleic acid with CYP5619A1 model. The ligand is displayed 
in thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.14. Interaction of palmitoleic acid with CYP5619A1 model. The ligand is displayed 
in thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.15. Interaction of oleic acid with CYP5619A1 model. The ligand is displayed in 
thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.16. Interaction of linoleic acid with CYP5619A1 model. The ligand is displayed in 
thick lines and the interacting residues in thin lines. The residues are labelled by three-letter 
codes and position in the protein sequence. The heme iron is also labelled. Colour coding is as 
follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen bonds are 
displayed as green dots and the atoms involved are accentuated by spheres coloured as per the 
respective atoms. 
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Figure 3.17. Interaction of alpha-linolenic acid with CYP5619A1 model. The ligand is 
displayed in thick lines and the interacting residues in thin lines. The residues are labelled by 
three-letter codes and position in the protein sequence. The heme iron is also labelled. Colour 
coding is as follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen 
bonds are displayed as green dots and the atoms involved are accentuated by spheres coloured 
as per the respective atoms. 
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Figure 3.18. Interaction of arachidonic acid with CYP5619A1 model. The ligand is 
displayed in thick lines and the interacting residues in thin lines. The residues are labelled by 
three-letter codes and position in the protein sequence. The heme iron is also labelled. Colour 
coding is as follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen 
bonds are displayed as green dots and the atoms involved are accentuated by spheres coloured 
as per the respective atoms. 
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Figure 3.19. Interaction of eicosapentaenoic acid with CYP5619A1 model. The ligand is 
displayed in thick lines and the interacting residues in thin lines. The residues are labelled by 
three-letter codes and position in the protein sequence. The heme iron is also labelled. Colour 
coding is as follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen 
bonds are displayed as green dots and the atoms involved are accentuated by spheres coloured 
as per the respective atoms. 
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Figure 3.20. Interaction of malachite green with CYP5619A1 model. The ligand is 
displayed in thick lines and the interacting residues in thin lines. The residues are labelled by 
three-letter codes and position in the protein sequence. The heme iron is also labelled. Colour 
coding is as follows: white, hydrogen; red, oxygen; blue, nitrogen; yellow, sulphur. Hydrogen 
bonds are displayed as green dots and the atoms involved are accentuated by spheres coloured 
as per the respective atoms. 
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The molecular docking studies showed that EIC and MGR form a better complex than 
others with the lowest free binding energy of -6.70 kcal/mol (Figure 3.21). EIC forms a tight 
hydrogen bond with residue Arg162 of the CYP5619A1 model (Figure 3.16).   
However, EIC conformations show a pattern of instability that is observed when 
comparing the binding energies of its different poses to those of MGR (Figure 3.22), suggesting 
that despite the same binding energy of their best conformations and MGR’s life-threatening 
properties, MGR remains the best compound that possibly inhibits the metabolic action of 
CYP5619A1. Nonetheless, this comparison is limited to a small set of docked ligands and might 
not constitute a tangible argument to draw conclusions. 
Furthermore, analysis of amino acid residues interacting with different ligands (11 
possible substrates and MGR) revealed that most of the residues interacting with different 
ligands are the same, suggesting that all ligands are interacting with almost the same amino 
acids and the binding patterns are conserved (Table 3.2). 
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Figure 3.21. Graphic representation of the free binding energies of the docked possible 
substrates and malachite green. Abbreviations: MYR: myristic acid; PLM: palmitic acid; 
STE: stearic acid; DCR: icosanoic acid; MYZ: myristoleic acid; PAM: palmitoleic acid; OLE: 
oleic acid; EIC: linoleic acid; LNL: alpha-linolenic acid; ACD: arachidonic acid; EPA: 
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Figure 3.22. Graphic comparison of binding energies for each conformation of the best 
two ligands. The binding energy for each of the 10 conformations of linoleic acid is plotted in 
orange. The binding energy for each of the 10 conformations of malachite green is plotted in 
blue. The trend for each ligand is plotted as a dashed line of the same colour. 
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MYR Arg162 (2HB), Cys228, Met229, Gly232, Pro297, His299, Met300, HEM413 
PLM 
Leu61, Leu65, Met158, Arg162 (2HB), Cys228, His225, Met229, Pro297, 
His299, Tyr301, HEM413 
STE 
Leu61, Leu65, Arg162 (2HB), Cys228, Met229, Gly232, Gly233,Trp237, 
Pro297, Tyr301, HEM413 
DCR 
Leu61, Arg162 (1HB), Met229, Gly232, Gly233, Trp237, Pro297, His299, 
Thr407, HEM413 
MYZ 
Pro74, Arg162 (2HB), His225, Cys228, Met229, Gly232, Gly233, Pro297, 
HEM413 
PAM 
Leu69, Pro74, Arg162 (2HB), His225, Cys228, Met229, Gly232, Gly233, 
Pro297, HEM413 
OLA 
Leu61, Leu65, Arg162 (2HB), His225, Cys228, Met229, Gly232, Gly233, 
Pro297, His299, Met300, Tyr301, HEM413 
EIC 
Leu69, Leu161, Arg162 (2HB), His225, Cys228, Met229, Gly232, Gly233, 
Trp237, Pro297, Leu408, HEM413 
LNL 
Leu61, Arg162 (2HB), Cys228, Met229, Gly232, Gly233, Trp237, Pro297, 
His299, Met300, Tyr301, HEM413 
ACD 
Tyr9, Arg14 (1HB), Leu61, Met229, Gly233, Trp237, Pro297, His299, 
HEM413 
EPA 
Leu61, Leu65, Pro74, Arg162 (1HB), His225, Cys228, Met229, Gly232, 
Gly233, Pro297, Thr407, HEM413 
MGR 
Leu61, Leu65, Pro74, Met229, Gly232, Gly233, Trp237, Pro297, His299, 
Tyr301, HEM413 
Abbreviations: MYR: myristic acid; PLM: palmitic acid; STE: stearic acid; DCR: 
icosanoic acid; MYZ: myristoleic acid; PAM: palmitoleic acid; OLE: oleic acid; EIC: linole ic 
acid; LNL: alpha-linolenic acid; ACD: arachidonic acid; EPA: eicosapentaenoic acid; MGR: 
malachite green. 
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3.4. Conclusion 
In this study, a 3D model of CYP5619A1 from S. diclina was built by homology modeling and 
assessed for its binding affinity with different predicted substrates based on homolog protein 
with the same motifs from fungi and with MGR remedy used to treat S. diclina infections. The 
study revealed that eight of the compounds required low energy to bind to the target protein, 
with binding energies below -6.00 kcal/mol. This suggests that these ligands can act as possible 
substrates of CYP5619A1. Among all ligands, EIC and MGR showed high binding affinity 
with the CYP5619A1 model. EIC is a polyunsaturated fatty acid with 18 carbon atoms and two 
double bonds in its structure. MGR is an organic compound that is widely used in aquaculture 
to treat S. diclina infections. These two compounds appeared to be the compounds with the best 
affinities to the target protein. In this regard, it is reasonable to believe that EIC-like compounds 
could be potential substrates for CYP5619A1 and MGR, possibly inhibiting CYP5619A1 in S. 
diclina. 
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CHAPTER 4 
CLONING AND GENERATION OF RECOMBINANT ESCHERICHIA COLI CELLS 
CONTAINING SAPROLEGNIA DICLINA’S CYP5619A1 IN pINK-d EXPRESSION 
VECTOR 
4.1. Introduction 
The concept of gene amplification has been recognised over millennia, although limited to 
phenotypic observation, because of lack of knowledge. By 5000 BC humans had already 
discovered that they could improve corn crops by sowing the seeds selected from the best 
plants. Since the establishment of the basic laws of inheritance by the father of genetics, 
Gregor Mendel, in 1866, the gene has become the cornerstone of most molecular biology 
technologies. It all evolved into the extraction of the now-known DNA, from the nuclei of 
leucocytes by Johann Friedrick Miescher in 1869, the establishment of chromosomes as 
bearers of genetic information by Walter Sutton in 1902, the discovery of the sugar 
deoxyribose in DNA by Pheobus Levene in 1929 and the finding of the DNA structure by 
Watson and Crick in 1953. This knowledge has long been used to understand natural cloning 
or natural reproduction, and to perform artificial cloning processes such as cell cloning, 
organism cloning and molecular cloning. In molecular cloning the process involves making 
multiple molecules and is used to amplify DNA fragments containing whole genes, as well as 
non-coding DNA sequences, randomly fragmented DNA, and DNA sequences such as 
promoters. These processes evolved with the “cracking” of the genetic code (determining 
which codon sequences specify each of the 20 amino acids) by Niremberg, Mathaei, and 
Ochoa in 1966 and the isolation of the enzyme DNA-ligase, the first gene and the first 
restriction enzyme (RE), in 1967, 1969 and 1970 respectively. In 1972, Paul Berg created the 
first recombinant DNA. Although naturally occurring genetic processes such as crossing-
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overs can technically produce recombinant DNA, the term usually refers to a DNA molecule 
that results from the combination of two DNAs from different origins, one containing the 
sequence of the gene of interest, and the other acting as a vehicle or vector that can replicate 
itself in living host cells. In 1983 Kary B. Mullis developed the polymerase chain reaction 
(PCR) technique to synthesise DNA rapidly and to be able to transform large amounts into 
vectors and host cells. The reaction can also be used to confirm the presence of the insert in 
the cells obtained and thus to guarantee the success of the cloning. 
 Generally, the cloning of a DNA fragment would involve four steps, namely: (i) the 
fragmentation of the vector, (ii) the ligation of the gene of interest, (iii) the transfection of the 
recombinant DNA, or transformation of host cell, and (iv) the screening or selection of 
successfully transformed host cells. Although these steps are standard in cloning procedures, 
different cloning strategies can be used, involving a particular strategy for each of the above-
mentioned steps. For instance, the cleavage of a vector can be done at a specific recognition 
site by using REs, which can cut both strands at the same spot, creating blunt ends, or at 
different spots, creating sticky ends. Furthermore, the transformation of the host cell can be 
done through different methods: one can allow the entry of the recombinant DNA into the cell 
by increasing its permeability with chemicals, heat shocks, or an electric field, or by 
mechanically introducing the vector into the host cell through optical injection or the use of a 
biolistic particle delivery system. 
 The choice of expression system is also a crucial part of the cloning process. Some of 
the expression systems that are most suitable for large-scale production of proteins include the 
prokaryotic Escherichia coli cells, yeast, baculovirus infected insect cells, and mammalian 
cells (the human embryonic kidney – HEK, and the Chinese hamster ovary – CHO). Since 
each of those expression systems offers advantages and disadvantages, one must take into 
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account some characteristics such as the cell growth rate, the complexity of the growth 
medium and its cost, the level of expression, and probable posttranslational modifications in 
the form of N- or O-linked glycosylation, any phosphorylation, acetylation, acylation or 
gamma-carboxylation. E. coli has proven to be the cheapest, quickest and thus the easiest of 
these expression systems. It is also the most standardized expression system, with established 
vectors, strains and protocols commercially available. For these reasons a strain of E. coli and 
its relevant expression system were used in this study to express CYP5619A1. 
4.2. Methodology 
4.2.1. Target DNA sequence 
The sequence of CYP5619A1 was taken from an article published by the Unit for Drug 
Discovery Research’s laboratory at CUT (Sello et al., 2015). 
4.2.2. Novel expression vector 
The vector used in this study was initially a kind gift from the late Dr Naheed Kaderbhai, 
Institute of Biological Sciences, University of Wales, Aberystwyth, Ceredigion, SY23 3DD, 
United Kingdom. The pINK-a vector’s multiple cloning site has been modified so as to 
circumvent the difficulty observed by researchers, in cloning and expressing Mycobacterium 
tuberculosis P450s (Kgosiemang, 2017). A set of steps were carried out to make the vector 
adequate for cloning and expression. Because the final results are going to be patented and 
commercial aspects are involved, some features of the expression vector will not be displayed. 
4.2.3. Restriction enzymes profiling  
The REs were selected from the novel vector’s MCS. The cleaving and non-cleaving abilities 
were assessed using the freely available software pDRAW (http://www.acaclone.com/), 
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where their recognition sites were explicitly selected on the sequence of the gene of interest. 
Moreover, the New England Biolabs (NEB) website 
(https://www.neb.com/products/restriction-endonucleases) was accessed to obtain sequences 
of the enzymes’ recognition sites. Among the three types of restriction endonucleases (Bächi 
et al., 1979; Kauc & Piekarowicz, 1978; Nathans & Smith, 1975), the use of type II REs was 
preferred, for they have a predictable pattern and do not require ATP, like types I and III. 
Moreover, type II REs make cuts directly at the restriction site, unlike type I that makes cuts 
hundreds of base pairs away from the restriction site (Lautenberger et al., 1978). The purpose 
of this evaluation was to select two REs belonging to the vector’s MCS, which did not have 
recognition sites on the gene of interest, in order to design the primers. 
4.2.4. Primer design 
The forward primer was designed by aligning a random, non-coding nucleotide sequence of 
six base pairs, the RE’s sequence, and at least 21 (here 22) of the first base pairs from the 5’- 
to 3’- sequence of CYP5619A1, in that particular order.  
The reverse primer consisted of a random, non-coding nucleotide sequence of five 
base pairs, the RE’s sequence, and at least 21 of the first base pairs from the 5’- to 3’- 
complementary sequence of CYP5619A1, in that specific order. 
The “Oligo Analyser 3.1” tool in the Integrated DNA Technology (IDT) program 
(https://eu.idtdna.com/calc/analyzer) was used to analyse the primers and adjust the random 
nucleotide sequences, in order to have adequate annealing temperatures that match for both 
forward and reverse primers. 
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4.2.5. Strains, plasmids, chemicals and kits 
E. coli DH5α strain was used in this study. The cells were cultured on Luria-Bertani (LB) 
broth and LB-agar (LB broth supplemented with 10 g/L agar). For selection of recombinant 
E. coli cells, the LB broth was supplied with antibiotic ampicillin (Amp). LB-Amp plates 
were prepared by adding Amp at 100 µg/ml final concentration. The Amp stock solution was 
prepared by dissolving 100 mg of Amp (Catalog No. A6140, Sigma-Aldrich, USA) in 1 ml of 
DNAse and RNase free water (Catalog No. L3152, Sigma-Aldrich, USA). The Amp stock 
solution was stored at -20oC. The pINK-d expression vector was used for the cloning of 
CYP5619A1. All chemicals used were of high quality and were purchased from Sigma-
Aldrich and Merck. The plasmid isolation kit was purchased from Qiagen, USA. 
4.2.6. Gene cloning and in-frame analysis 
The novel vector’s sequence was inserted in the pDRAW software and the DNA property was 
changed to “circular”. The vector was annotated as per the vector’s map. The sequence was 
then truncated at the RE site, and the CYP5619A1 sequence was inserted and annotated. The 
Translate tool from ExPASy (http://web.expasy.org/translate/) was used to ensure that the 
gene of interest remained in frame after cloning. 
4.2.7. Gene synthesis 
Following the in silico cloning of CYP5619A1 into the vector, the nucleotide sequences were 
submitted to a gene manufacturing company (GenScript USA Inc, USA), along with the 
primers’ sequences and cloning strategy. The plasmid, CYP5619A1 and the primers were 
manufactured, and CYP5619A1 was cloned into the novel vector, with Res, KpnI and XbaI. 
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4.2.8. Transformation 
Following the cloning of the gene of interest CYP5619A1 into the newly-designed vector, the 
vector obtained with the CYP5619A1 gene had to be transfected into E. coli cells to enable its 
expression and thus assess the activity.  
The host cells (E. coli DH5-α) were transformed with the plasmid obtained from the cloning 
by using the HEPES E. coli transformation method described by Inoue and co-workers 
(1990).  
4.2.8.1. Preparation of TB-Buffer 
The buffer was prepared by making a 100 ml aqueous solution of 0.26 g of 10 mM HEPES 
pH 6.7, 0.2206 g of 15 mM CaCl2 and 1.8638 g of 250 mM KCl. The solution was adjusted to 
pH 6.7 with KOH/HCl. Then 1.0886 g of 55 mM MnCl2 was added and the solution was 
filtered with a sterile 0.22 µm filter and stored at 4°C. 
4.2.8.2. Preparation of SOB medium 
The SOB medium was prepared by making a 1500 ml aqueous solution of 10 g of tryptone, 
2.5 g of yeast extract, 0.292 g of NaCl, 0.093 g of KCl, 1.017 g of MgCl2 and 1.232 g of 
MgSO4. The solution was mixed well and divided into 250 ml aliquots in 1 l Erlenmeyer 
flasks and autoclaved at 121°C for 20 min. 
4.2.8.3. Preparation of the SOC medium 
The procedure is the same as that for the SOB medium. In addition, 20 ml of sterile 1 M 
glucose was added after autoclaving. 
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4.2.8.4. Preparation of competent cells 
5 µl of E. coli DH5-α glycerol stock was used to inoculate 5 ml LB early in the morning and 
the inoculum was incubated for 10 hours, while shaking at 37°C. The full 5 ml inoculum was 
then transferred to 250 ml SOB media in a 1 l flask and grown at 18°C overnight on a shaker, 
until an OD600 of approximately 0.55 had been reached. The flask was then put in an ice-water 
slurry for 10 min, after which the culture was transferred to a pre-cooled centrifuge bottle and 
spun at 2500 xg for 10 min at 4°C. The supernatant was decanted and the cells were gently re-
suspended in 16 ml of ice-cold TB in the fridge. The suspension was put on ice for 10 min 
and then centrifuged at 2500 x g for 10 min at 4°C. The cells were gently re-suspended in 4 
ml of ice-cold TB. 300 µl of DMSO was added to a final concentration of 7%, and the 
suspension was put on ice for 10 min. Finally, aliquots of 100 µl per pre-cooled tubes were 
made, snap-frozen in liquid nitrogen and stored at -80°C. 
4.2.8.5. Transformation of E. coli DH5-alpha cells 
The competent cells were removed from -80°C and thawed on ice. The recombinant plasmid 
DNA was added to the cells at a concentration of 10% v/v. A flix cube was used to mix it and 
the mixture was incubated on ice for 20 min. The cells were then immersed in a 42°C water 
bath for 60 sec, and immediately incubated in ice-water slurry for 2 min. 250 µl of SOC was 
added and the mixture was incubated at 37°C in a water bath for 1 hour. The pellet cells were 
then spun at 2500 xg for 5 min and the supernatant was decanted until approximately 100 µl 
was left. The pellet was re-suspended in the remaining supernatant and plated onto an 
ampicillin medium. The plates were incubated at 37°C for 20 hours. 
 
 
© Central University of Technology, Free State
CHAPTER 4: CLONING AND GENERATION OF RECOMBINANT ESCHERICHIA COLI CELLS CONTAINING SAPROLEGNIA 
DICLINA’S CYP5619A1 IN pINK-d EXPRESSION VECTOR 
 
124 | P a g e  
 
4.2.9. Plasmid isolation and purification 
Plasmid isolation and purification from the recombinant cells were carried out using the 
QIAprep Spin Miniprep Kit (Catalog No. 27104, Qiagen, Germany) following the 
manufacturer’s protocol. Plasmid DNA concentration was carried out using the SimpliNano 
microvolume spectrophotometer (Catalog No. GE29-0617-13, Sigma-Aldrich, USA). 
4.2.10. Restriction enzyme analysis of the plasmids 
The isolated plasmids from recombinant E. coli cells were subjected to restriction enzyme 
digestion to confirm the presence of the inserts and the correct size of the cloned CYP5619A1 
cDNA. All restriction enzymes used in this study were purchased from NEB, South Africa. 
Digested DNA fragments were analysed on a 1% agarose gel. Visualisation of DNA 
fragments was carried out using SYBR® Sae DNA gel stain (Catalog No. S33102, Thermo 
Fisher Scientific, USA). The agarose gel was photographed using the Gel DocTM EZ System 
(Bio-Rad, South Africa). 
4.3. Results and discussion 
4.3.1. Re-engineered expression vector and sequence landmarks 
The pINK-a vector was re-engineered at its MCS. More recognition sites were incorporated 
initially to be able to clone different P450s (Table 4.1).  
 The vector was annotated on pDRAW and renamed pINK-d (Figure 4.1). pINK-d is a 
circular extra-chromosomal DNA molecule that will be able to replicate independently of the 
host cell’s genome. 
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Table 4.1. Restriction enzymes incorporated in the multiple cloning site of the expression 
vector. The restriction enzymes and their recognition sequences are shown in the table. 
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Factor Xa site - 2524
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4.3.2. Restriction enzymes selection 
The selected REs for the cloning of the gene of interest are KpnI and XbaI. They are 
part of the vector’s MCS, and do not cut CYP5619A1.  
KpnI recognises the sequence given below: 
 
XbaI recognises the sequence given below: 
 
Both enzymes, KpnI and XbaI, cause sticky ends restrictions.  The cuts are made on 
the two DNA strands, four base-pairs from each other, creating a four-base 5'-overhang in one 
molecule and a complementary 5'-overhang in the other. Moreover, their sequences are 
palindromic, which means that they can be read the same on two strands in the 5’- to 3’- and 
3’- to 5’-directions. 
4.3.3. CYP5619A1 primers 
Primers are short, single-stranded nucleic acid sequences. When attached to a single-stranded 
template molecule, they serve as starting point for the synthesis of a complementary DNA 
strand, directed by a DNA polymerase. The following is the ORF of the gene of interest: 
Coding:  5’- ATGGGCAACCTCACCAGCACTGGCGCG […] 
CCCAACACGATGGAGATGGCCGTGAGCATCTAA -3’ 
Complementary: 3’- TACCCGTTGGAGTGGTCGTGACCGCGC […] 
GGGTTGTGCTACCTCTACCGGCACTCGTAGATT -5’ 
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It shows the presence of a start (ATG) and a stop (TAA) codon, as well as the coding (5’- to 
3’-) and the complementary (3’- to 5’-) sequences. Restriction site analysis using the software 
pDRAW showed that the sequence contained neither KpnI nor XbaI restriction sites. 
To design the forward primer, the first 22 nucleotides were selected on the coding 
sequence of CYP5619A1: 
5’- ATG GGC AAC CTC ACC AGC ACT G -3’ 
It is necessary that the 3’- end of a primer be G or C, for they have stronger bonds. In 
addition, the sequence already begins with a start (ATG) codon, since the gene is being cloned 
from the very beginning. If cloned from the middle, a start codon would have been added. The 
KpnI site was then added to the 5’- end of the sequence: 
5’- GGT ACC ATG GGC AAC CTC ACC AGC ACT G 
The last step is adding a random, non-coding nucleotide sequence. The reason for this 
is to have enough support for the enzyme to attach to its restriction site. 
5’- NNN NNN GGT ACC ATG GGC AAC CTC ACC AGC ACT G 
The designing of the reverse primer started in a similar way, by selecting the last 21 
bases in the sequence: 
5'- TTA GAT GCT CAC GGC CAT CTC C 
The sequence that was picked was the complementary sequence of the coding 
sequence, and the primer was written in the 5’- to 3’-direction for the ordering. The XbaI 
restriction sequence was then added: 
5'- TCT AGA TTA GAT GCT CAC GGC CAT CTC C 
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Finally, as on the forward primer, a random, non-coding nucleotide sequence was 
added at the 5’-end of the restriction site, in order to have enough support for the enzyme to 
attach. 
5'- NNN NNN TCT AGA GAT GCT CAC GGC CAT CTC CAT C 
The primers obtained were analysed using the “OligoAnalyser 3.1” tool, from the IDT 
online program (https://eu.idtdna.com/calc/analyzer) and the results (Table 4.2) allowed to 
observe the melting temperature (Tm) and hence to adjust the annealing temperatures to 
nearly similar values, by modifying the random sequences at the 5’-end of the primers. 
Replacing A and T by either G or C would increase the annealing temperatures, because of 
the stronger bonds of those nucleotides, while replacing G and C by either A or T would 
decrease the annealing temperatures, because of the weaker bonds of those nucleotides. In 
addition, the primers were assessed using pDRAW, for the presence of any methylation.  
The final designed primers were obtained as follows: 
CYP5619A1-FP-KpnI 
5’- AAT TAA GGT ACC ATG GGC AAC CTC ACC AGC ACT G -3’ 
CYP5619A1-RP-XbaI 
5’- GC GGC TCT AGA TTA GAT GCT CAC GGC CAT CTC -3’ 
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Table 4.2. Details of the CYP5619A1 primers. The underlined sections of the sequences are 
the REs' recognition site.  
Primer’s code CYP5619A1-FP-KpnI CYP5619A1-RP-XbaI 
5’-3’ sequence AAT TAA GGT ACC 
ATG GGC AAC CTC 
ACC AGC ACT G 
GC GGC TCT AGA TTA 
GAT GCT CAC GGC 
CAT CTC 
Oligo concentration 0.25 µM 0.25 µM 
Length 34 32 
G-C content 50 % 56.2 % 
Melting temperature 65.5 °C 65.5 °C 
Molecular weight  10404.8 g/mol 9776.4 g/mol 
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The pDRAW software was used to ensure that the primers did not contain any 
methylation. Methylation of one or both strands would result in the protection of the enzymes’ 
restriction sites against the binding of those enzymes, thereby inhibiting the enzymes’ 
activity. Although it is not the only possible cause, it is important to verify that factor, to 
avoid any of the methylation effects (McClelland, 1981). In this case, KpnI did not show any 
methylation, as the enzyme’s recognition site is not sensitive to methylation by Dam, Dcm 
and CpG. On the other hand it was made certain that XbaI would not be blocked if Dam 
overlapped its recognition site. 
4.3.4. In silico cloning of CYP5619A1 in pINK-d  
In silico cloning of CYP5619A1 into pINK-d was carried out using the software pDRAW. A 
preview of the modified gene was made. From that preview, it was clear that the vector and 
the gene of interest (pINK-d and CYP5619A1) could be attached, using both KpnI and XbaI 
REs. The plasmid was cleaved by the enzymes, and the insert was attached. The results from 
the pDRAW software and the preview clearly showed the pINK-d_CYP5619A1 map (Figure 
4.2). 
 Furthermore, the sequence was assessed to detect any frame shift that could occur after 
the cloning of CYP5619A1. Here, the Translate tool from ExPASy website 
(http://web.expasy.org/translate/) was used. The sequence of the pINK-d_CYP5619A1 was 
entered in the ExPASy Translate tool. The entered sequence goes from the start codon (ATG) 
following the Shine-Dalgarno sequence, and ends at the stop codon (TGA) of the MCS. The 
sequence was submitted for translation after requesting the result in a compact output format. 
The results obtained are displayed in Table 4.3. 
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Table 4.3. In-frame analysis of CYP5619A1 in pINK-d vector. The highlighted sections of 
the sequences are the start and the end of the CYP5619A1 amino acids sequence, confirming 
that no frame shift has occurred during the cloning. 
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This clearly shows that there has been no frame shift during the in silico cloning of 
CYP5619A1 and the CYP5619A1 will be expressed properly. 
4.3.5. Synthesis of pINK-d_CYP5619A1  
The gene sequence was sent to a gene-manufacturing company, GenScript, which is well-
known for its good quality products. The vector, pINK-d, and the gene, CYP5619A1, were 
synthesised. The latter was cloned into pINK-d using KpnI and XbaI REs (Figure 4.3) and the 
products were received in a microtiter plate. The constructs and the expression vector were 
resuspended in 100 µl of Tris-Hcl buffer (pH: 8.0) and 1 µl of this solution was used for 
transformation. 
 The restriction sites, highlighted in the figure (Figue 4.3), are linked to the extremities 
of the gene of interest CYP5619A1. This is proof that the gene was cloned perfectly into the 
vector pINK-d and can be expressed properly. 
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Figure 4.3. Sequencing analysis of CYP5619A1 in pINK-d vector. The figure shows the 
restriction sites (highlighted) and the sequence of the gene of interest CYP5619A1. 
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4.3.6. Transformation of the recombinant plasmid into E. coli DH5α cells 
Competent E. coli DH5-α cells were prepared as described in the methodology. These are 
cells that are able to take up extracellular DNA from their environment. The biochemical 
mechanisms that underlie that capacity is explained by many authors (Lévy et al., 1990; 
Dorocicz et al., 1993; MacFadyen et al., 1996; Wang et al., 2002; Bossé et al., 2004; 
Barabote & Saier, 2005; Bigas et al., 2005; Gioia et al., 2006). 
 The plasmid pINK-d_CYP5619A1 was successfully transfected into E. coli DH5-α 
using the E. coli transformation procedure described above (Inoue et al., 1990). Some cells 
took up the plasmids, which contained a gene for Amp resistance. Therefore the cells were 
screened on an Amp-containing medium (Figure 4.4), which only allowed the growth of the 
transformed cells. The reason for this growth is that the Amp resistance gene (AmpR) 
contained in the plasmid pINK-d codes for a β-lactamase: penicillin amido-β-lactamhydrolase, 
an enzyme that cleaves the β-lactam ring of penicillin and related antibiotics (Sutcliffe, 1978). 
The amide bond of the β-lactam ring is hydrolysed to produce penicilloic acid, which exhibits 
no antibiotic activity. The E. coli DH5-α strains transformed with pINK-d_CYP5619A1 
produce that enzyme, which is secreted into the periplasmic space of the bacterium, where it 
performs its activity and detoxifies the Amp in the LB-media. 
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Figure 4.4. Transformation of pINK-d_CYP5619A1 into E. coli DH5α and screening of 
the transformed cells on LB medium containing Ampicillin antibiotic. A: Untransformed 
cells on LB medium with Ampicillin; B: Transformed cells on LB medium with Ampicillin. 
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4.3.7. Plasmid isolation and confirmation of the presence of CYP5619A1 cDNA 
In order to confirm the presence of the gene of interest in the transformed cells, the latter were 
isolated and assessed. Firstly, colonies of the transformed E. coli DH5α were inoculated into 
10 ml of LB broth and incubated at 37oC and 150 rpm. The overnight bacterial culture was 
used for the isolation of plasmids. The plasmid DNA was extracted using the QIAprep Spin 
Miniprep Kit and the concentration of the plasmid DNA was measured (Table 4.4) before 
being subjected to RE (KpnI and XbaI) digestion analysis. 
 On lane A, two bands are visible. One represents the plasmids that have a supercoiled 
conformation. Plasmids with that conformation run faster in agarose gels than they are 
expected to, since they are not trapped (Akerman, 1998). For that reason, the band appears as 
that of a 4000 bp DNA sequence, though the plasmid has a 6024-bp long sequence. On the 
other hand, the nicked, relaxed circular form of the plasmid being the slowest on the gel,  it 
appears between the 6000 and 8000 bands of the KB ladder. 
On lane B, two bands are visible. The fastest one appears to be a sequence of nearly 
3000 bp, which represents the CYP5619A1, with its 2913-bp long sequence. The second, 
slower one appears to be a sequence of slightly more than 3000-bp long, which is therefore 
assimilated to the pINK-d, with its 3111-bp long sequence. It is important to note that the 
original vector was 3143-bp long, but lost 32 bp in its MCS from the cleavage by the KpnI 
and XbaI REs. 
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Figure 4.5. Restriction enzyme digestion analysis of pINK-d_CYP5619A1. Lane A: 
undigested plasmid pINK-d_CYP5619A1; Lane B: digested plasmid (with KpnI and XbaI); 
Lane M: KB Ladder. Digestion conditions: 300 ng of plasmid digested in water bath, 37°C 
for 40 min. 1% agarose gel. 
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4.4. Conclusion 
The aim of this chapter was to clone the gene of interest CYP5619A1 into the newlydesigned 
vector pINK-d using in silico, as well as wet-laboratory techniques, in order to be able, at later 
stages, to express CYP5619A1 and assess the activity of this P450. The gene was cloned into 
the novel vector using the software pDRAW and the sequence of the designed primers; the 
vector and gene of interest were sent to GenScript. The results obtained were satisfactory, as 
the gene was perfectly cloned into the vector, which was verified by running the plasmid 
through an agarose gel on the one hand, and the plasmid restricted by the KpnI and XbaI 
enzymes on the other hand. The gel analysis confirmed the presence of CYP5619A1. 
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CHAPTER 5 
CONCLUSION AND FUTURE PERSPECTIVES 
 
In conclusion, in this study, phylogenetic analysis and in silico structural and functional 
analysis of the novel P450 family CYP5619 from oomycetes have been carried out. This 
study revealed that the CYP5619 family is not limited to oomycetes, but is also present in 
other microbes. In silico structural and functional analysis revealed that CYP5619A1 is 
predicted to be capable of oxidising fatty acids, linoleic acid and to tightly bind to malachite 
green, the agent used to kill oomycetes. Future study could include the expression and 
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RESEARCH OUTPUTS 
The research done during the doctoral programme produced conference outputs, as well as 
articles in peer-reviewed journals.   
1. Conference abstract/poster presentations  
Results from this study have been presented in the form of posters at national and 
international conferences detailed below: 
1. Bamal HD, Mashele SS, Tuszynski JA, Syed K (2017). Phylogenetic and comprehensive 
in silico structural and functional analysis of CYP5619 from Saprolegnia diclina. The Annual 
South African Pharmacology Conference, Faculty of Health Sciences, University of the Free 
State, Bloemfontein, 01
st
 – 04th October. 
2. Bamal HD, Mashele SS, Tuszynski JA, Syed K (2017). In silico structural and functional 
characterisation of a novel cytochrome P450 CYP5619A1 from Saprolegnia diclina. 20
th
 
International Conference on Cytochrome P450s: Biochemistry, Biophysics and 
Biotechnology, August 27-31, Dusseldorf, Germany. 
3. Bamal HD, Mashele S, Syed K (2016) Structural analysis of a novel P450 family 
CYP5619 from pathogenic oomycete Saprolegnia diclina. The 13th International Symposium 
on Cytochrome P450 Biodiversity and Biotechnology, 22-26 July 2016, Vancouver, BC, 
Canada. P72-S2. 
4. Bamal HD, Mashele S, W Chen, Syed K (2015) Understanding the P450 subfamily 
evolution in biotechnologically valuable and catalytically versatile P450 families CYP63 and 
CYP5136. International Symposium on Methods for Studying Drug Metabolism and 
Transport, and African Traditional Medicines (METHODS-2015) from 23-25 November 
2015 at St Georges Hotel and Conference Center, Pretoria, South Africa. DMP07.6.1.  
© Central University of Technology, Free State
RESEARCH OUTPUTS 
 
148 | P a g e  
 
2. Publications and supervisions 
An article detailing the study findings is in preparation for submission to the journal “Marine 
Drug” (ISSN 1660-3397; IF 3.503) and will be as follows: 
Bamal HD, Mashele SS, Tuszynski JA, Syed K (2017) In silico structural and functional 
analysis of novel P450 family CYP5619 from deadliest oomycetes pathogen Saprolegnia 
diclina. Marine Drugs (soon to be communicated). 
During the course of the program, four B Tech projects and three Masters projects (three 
students) were supervised. In view of this contribution, co-authorship was earned in articles 
in high-impact factor journals such as Scientific Reports and BBA Proteins and Proteomics. 
Details of the manuscripts are as follows: 
1. Bamal HD (co-author) (2017) In silico analysis of cytochrome P450 monooxygenases in 
chronic granulomatous infectious fungus Sporothrix schenckii: special focus on CYP51. BBA 
Proteins and Proteomics (BBAPRO-17-174R1). 
2. BAMAL HD (co-author) (2016) Molecular evolutionary dynamics of cytochrome P450 
monooxygenases across kingdoms: special focus on mycobacterial P450s. Scientific reports, 
6, p.33099. 
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